Method for transforming bacterium belonging to genus bifidobacterium
Patent Information
- Application Number
- MYPI2025005963
- Authority / Receiving Office
- MY · MY
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-03-31
- Filing Date
- 2024-03-29
- Publication Date
- 2024-09-30
AI Technical Summary
Bifidobacterium bacteria are difficult to genetically manipulate due to low transformation efficiency, and there is a lack of understanding and reports on horizontal gene transfer in this species, which limits the ability to efficiently transform and edit their genomes.
A method involving static culture of Bifidobacterium bacteria with bacteria or linear DNA as a donor, using a medium with specific pH and sugar content, and incorporating genes like the Tad pili gene operon and DNA processing enzymes, allows for efficient transformation and genome manipulation by homologous recombination.
This method enables efficient transformation and genome editing of Bifidobacterium bacteria, overcoming the challenges of low transformation efficiency and allowing for the introduction of new phenotypes and genes, such as the xylanase gene, into probiotic strains.
Smart Images

Figure PI2025005963_DRAWING_001 
Figure PI2025005963_DRAWING_002 
Figure PI2025005963_DRAWING_003
Abstract
Description
Method for transforming Bifidobacterium
[0001] The present invention relates to a method for transforming bacteria of the genus Bifidobacterium.
[0002] Bifidobacterium is a gram-positive, obligately anaerobic bacterium that is a major bacterium in the human intestinal flora and is known to have beneficial effects on human health, such as intestinal regulating effects such as improving constipation and diarrhea, suppressing serum cholesterol elevation, and immunostimulating effects. For this reason, many Bifidobacterium-containing bacteria are commercially available in the form of various fermented foods and beverages, probiotic preparations, and the like.
[0003] It has become clear that although Bifidobacterium bacteria are the same species, their phenotypes and genetic makeup differ from strain to strain. Such strain-level genetic diversity is commonly observed in major human resident bacteria such as Bifidobacterium breve, Bifidobacterium longum, and Bifidobacterium bifidum. Furthermore, when focusing on specific genes, it is often observed that the phylogenetic relationships between strains do not coincide with the presence or absence of the gene. A typical example is the xylanase (BpXyn10A) gene, which determines the assimilation of long-chain xylans. When strains carrying the xylanase gene are plotted on an accurate phylogenetic tree based on the genome information of Bifidobacterium pseudocatenulatum, they are not concentrated in a specific cluster but are dispersed throughout the tree (Non-Patent Document 1).
[0004] In bacteria that grow by binary fission, the genetic diversity at the strain level and the distribution of genes that do not match phylogenetic relationships are believed to be largely influenced by horizontal gene transfer (HGT). Common mechanisms of HGT include natural transformation, phage infection, and conjugative transfer of plasmids. HGT can significantly change genetic and phenotypic diversity in the short term, but the nature of HGT in Bifidobacterium bacteria is unknown, and there have been no reports of natural transformation occurring in Bifidobacterium bacteria.
[0005] Furthermore, compared to model organisms, Bifidobacterium species are known to be more difficult to artificially manipulate genetically (Non-Patent Documents 2 to 4). The main reason for the difficulty in genetic manipulation is thought to be the low transformation efficiency. Therefore, there is a need for an efficient method for transforming Bifidobacterium bacteria.
[0006] Watanabe, Y., Saito, Y., Hara, T. et al. ISME COMMUN. 1, 62, 2021. Vincenzo F. Brancaccio et al. Bioengineered 4:4, 197-202, 2013. Satoshi Fukiya, Atsushi Yokota Chemistry and Biology Vol. 55, No. 9, 2017. S. Fukiya, T. Suzuki. et al. "Lactic Acid Bacteria and Bifidobacteria: Current Progress in Advanced Research," Caister Academic Press, 31-51, 2011.
[0007] The present invention relates to providing an efficient method for transforming bacteria of the genus Bifidobacterium.
[0008] The present inventors have conducted extensive research into methods for transforming Bifidobacterium bacteria and have found that by contacting Bifidobacterium bacteria as a recipient with bacteria or linear DNA as a donor and statically culturing them in a specific medium, Bifidobacterium bacteria can be efficiently transformed by uptake of donor-derived DNA.
[0009] That is, the present invention provides the following [1] to [7]: [1] A method for transforming Bifidobacterium bacteria, comprising contacting a recipient Bifidobacterium bacterium with a donor bacterium or linear DNA containing DNA to be introduced into the recipient, and statically culturing the bacterium, wherein the medium used for the static culturing has a pH of 6.0 or higher and lower than 10.0, and the content x (mass%) of sugars assimilable by the recipient Bifidobacterium bacterium satisfies the following relationship: 0 < x ≦ 0.2 × (pH) − 1.2 when the pH is 6.0 or higher and lower than 8.5, and 0.2 × (pH) − 1.7 < x ≦ 0.2 × (pH) − 1.2 when the pH is 8.5 or higher and lower than 10.0. [2] A method for genome manipulation of Bifidobacterium bacteria, comprising contacting a recipient Bifidobacterium bacterium with a donor linear DNA and statically culturing the bacterium, wherein the medium used for the static culturing has a pH of 6.0 or higher but lower than 10.0, and the content x (mass%) of sugars assimilable by the recipient Bifidobacterium bacterium satisfies 0<x≦0.2×(pH)−1.2 when the pH is 6.0 or higher but lower than 8.5, and 0.2×(pH)−1.7<x≦0.2×(pH)−1.2 when the pH is 8.5 or higher but lower than 10.0, and the recipient Bifidobacterium bacterium does not have an upp gene; A method in which the linear DNA as the donor comprises an upstream homology arm, two genes, a selectable marker gene and an upp gene, and a downstream homology arm, the two genes being arranged between the upstream homology arm and the downstream homology arm, and the 3'-terminal region of the upstream homology arm being included between the two genes and the downstream homology arm, or the 5'-terminal region of the downstream homology arm being included between the upstream homology arm and the two genes.[3] The method according to [1] or [2], wherein the recipient Bifidobacterium bacterium has on its genome at least one gene selected from the group consisting of a Tad fimbrial gene operon, a DNA binding enzyme (ComEA) gene / DNA uptake enzyme (ComEC) gene operon, a DNA processing enzyme (DprA) gene, a nuclease (YraN) gene, and a helicase (ComM) gene. [4] The method according to [1] or [2], wherein the medium has an osmotic pressure of 110 to 750 mOsm. [5] The method according to [1] or [2], wherein the medium contains 3 to 180 mM MgCl. [6] A culture medium used in the method for transforming Bifidobacterium bacteria according to [1] or the method for genome manipulation of Bifidobacterium bacteria according to [2], wherein the culture medium has a pH of 6.0 or higher but lower than 10.0, and the content x (mass%) of sugars assimilable by the recipient Bifidobacterium bacteria satisfies the following relationship: 0 < x ≦ 0.2 × (pH) −1.2 when the pH is 6.0 or higher but lower than 8.5, and 0.2 × (pH) −1.7 < x ≦ 0.2 × (pH) −1.2 when the pH is 8.5 or higher but lower than 10.0. [7] A kit used in the method for genome manipulation of Bifidobacterium bacteria according to [2], comprising a medium having a pH of 6.0 or higher but less than 10.0, and a content x (mass%) of sugars assimilable by the recipient Bifidobacterium bacteria satisfying the following: 0 < x ≦ 0.2 × (pH) −1.2 when the pH is 6.0 or higher but less than 8.5, and 0.2 × (pH) −1.7 < x ≦ 0.2 × (pH) −1.2 when the pH is 8.5 or higher but less than 10.0; and linear DNA comprising a selection marker gene and an upp gene.
[0010] According to the present invention, it is possible to efficiently transform bacteria of the genus Bifidobacterium, which has previously been considered difficult to transform, and it becomes possible to breed existing probiotic strains, such as by editing any genomic region of Bifidobacterium bacteria or by imparting a new phenotype to Bifidobacterium bacteria.
[0011] An example of the genome structure of a strain (transformant) from Bifidobacterium pseudocatenulatum that has acquired the xylanase gene. The corresponding single nucleotide polymorphisms (SNPs) for each strain are indicated by gray lines. Growth curves in mPY-AX medium for the donor (Bifidobacterium pseudocatenulatum YIT 11027), recipient (Bifidobacterium pseudocatenulatum YIT 11956), and the gene-acquired strain (transformant). Growth curves in mPY-Starch medium for the donor (Bifidobacterium pseudocatenulatum YIT 11027), recipient (Bifidobacterium pseudocatenulatum YIT 11956), and the gene-acquired strain (transformant). Donor (Bifidobacterium pseudocatenulatum YIT 4072 T), recipient (Bifidobacterium pseudocatenulatum YIT 12824), and gene-acquired strains (transformants) in Tc-mGAML medium. Transformation frequency when (A) live or killed cells, (B) live cells, genomic DNA, or PCR product, and (C) DNase-treated live cells were used as donors. Effects of (A) pH, (B) lactose, (D) various salts, (E) magnesium chloride, (F) osmotic pressure, and (G) culture conditions on transformation. nd indicates not detected. (C) Sugar and pH ranges in which transformation occurs. (H) Transformation in commercially available medium. Schematic diagram of the markerless genome manipulation system. (A) An example of the genomic structure of a gene-acquired strain (transformant) of Bifidobacterium breve. (B) An example of the genomic structure of a gene-acquired strain (transformant) of Bifidobacterium longum. (C) An example of the genomic structure of a strain (transformant) that has acquired genes from a different bacterial species. Single nucleotide polymorphisms are indicated by gray lines. (A) Colony formation in Em-mGAML of a donor (Bifidobacterium breve BR-Cw104-C2 strain), a recipient (Bifidobacterium breve BR-Cw104-A1 strain), and a gene-acquired strain (transformant). (B) Colony formation in Em-mGAML of a donor (Bifidobacterium longum YIT 12812), a recipient (Bifidobacterium longum YIT 12762), and a gene-acquired strain (transformant). (C) Colony formation in Em-mGAML medium by the donor (Bifidobacterium longum LO-Cw098-B4 strain), recipient (Bifidobacterium breve BR-Cw104-A1 strain), and gene-acquired strain (transformant). Growth of Bifidobacterium pseudocatenulatum strains in a medium containing glucose as the sole sugar source.
[0012] In this specification, the abbreviations for base sequences, nucleic acids, etc. are written using symbols commonly used in the relevant field, such as the IUPAC-IUB standard (IUPAC-IUB communication on Biological Nomenclature, Eur. J. Biochem., 138:9-37, 1984), "Guidelines for the preparation of specifications, etc., including base sequences or amino acid sequences" (edited by the Japan Patent Office), etc. In this specification, "deoxyribonucleic acid (DNA)" encompasses not only double-stranded DNA, but also the single-stranded DNAs, that is, the sense strand and the antisense strand, which constitute it.
[0013] In this specification, the identity of nucleotide sequences is expressed as a percentage by aligning the two nucleic acid sequences to be compared so that as many bases as possible match, dividing the number of matched bases by the total number of bases. A person skilled in the art can determine the identity of nucleotide sequences by appropriately setting the parameters of software such as BLAST, ClustalX, or Genetyx.
[0014] As used herein, "nucleotide," "oligonucleotide," and "polynucleotide" are synonymous with nucleic acid and include both DNA and RNA. The DNA includes cDNA, genomic DNA, and synthetic DNA. The RNA includes total RNA, mRNA, rRNA, and synthetic RNA. Furthermore, "nucleotide," "oligonucleotide," and "polynucleotide" may be double-stranded or single-stranded, and unless otherwise specified, when referring to a "nucleotide" (or "oligonucleotide," "polynucleotide") having a certain sequence, this also comprehensively refers to a "nucleotide" (or "oligonucleotide," "polynucleotide") having a complementary sequence.
[0015] In this specification, the term "gene" includes double-stranded DNA including genomic DNA, single-stranded DNA (positive strand) including cDNA, single-stranded DNA (complementary strand) having a sequence complementary to the positive strand, and fragments thereof, and refers to DNA in which some biological information is contained in the sequence information of the bases that make up the DNA. Unless otherwise specified, the term "gene" refers to control regions, coding regions, exons, and introns without distinction.
[0016] As used herein, "expressibly linked" between a first gene and a second gene means that the first gene and the second gene are linked so that, when introduced into the genome of an appropriate bacterium, the protein encoded by the first gene and the protein encoded by the second gene are produced, respectively. Here, "linking" is a concept that encompasses both cases where the first gene and the second gene are directly linked and cases where they are linked via another base sequence. Procedures for "expressibly linked" between a first gene and a second gene are well known to those skilled in the art.
[0017] As used herein, "upstream" and "downstream" with respect to a gene or its nucleotide sequence refer to upstream and downstream in the transcription direction of the gene. For example, the "upstream sequence" and "downstream sequence" of a gene refer to the sequences located on the 5' and 3' sides of the gene, respectively, on the DNA sense strand.
[0018] As used herein, "transformation" refers to natural transformation in which bacteria take up extracellular DNA and retain it within their own genomic DNA, without relying on physicochemical treatments such as electroporation. As used herein, "donor" refers to the donor of DNA, and "recipient" refers to the recipient of the DNA.
[0019] The method for transforming Bifidobacterium bacteria of the present invention (hereinafter also referred to as the method of the present invention) comprises contacting a recipient Bifidobacterium bacterium with a donor bacterium or linear DNA comprising DNA to be introduced into the recipient, followed by static cultivation, wherein the medium used for the static cultivation has a pH of 6.0 or higher and lower than 10.0, and the content x (mass %) of sugars assimilable by the recipient Bifidobacterium bacteria satisfies the following relationship: 0<x≦0.2×(pH)−1.2 when the pH is 6.0 or higher and lower than 8.5, and 0.2×(pH)−1.7<x≦0.2×(pH)−1.2 when the pH is 8.5 or higher and lower than 10.0.
[0020] In the method of the present invention, the species of the Bifidobacterium bacterium to be transformed, in other words, the species of the Bifidobacterium bacterium as a recipient, is not particularly limited, and examples thereof include Bifidobacterium pseudocatenulatum, Bifidobacterium breve, Bifidobacterium longum, Bifidobacterium adolescentis, Bifidobacterium bifidum, Bifidobacterium animalis, Bifidobacterium suis, Bifidobacterium spp. ... Examples of suitable Bacteria include Bifidobacterium infantis (B. infantis), Bifidobacterium catenulatum (B. catenulatum), Bifidobacterium lactis (B. lactis), Bifidobacterium globosum (B. globosum), Bifidobacterium angulatum (B. angulatum), and Bifidobacterium dentium (B. dentium). Among these, Bifidobacterium pseudocatenulatum, Bifidobacterium breve, Bifidobacterium longum, Bifidobacterium adolescentis, or Bifidobacterium bifidum is preferred, and Bifidobacterium pseudocatenulatum, Bifidobacterium breve, or Bifidobacterium longum is more preferred.
[0021] The recipient Bifidobacterium bacterium is a Bifidobacterium bacterium having on its genome preferably at least one, more preferably at least three, and even more preferably all five genes selected from the group consisting of the Tad pilus gene operon, the DNA binding enzyme (ComEA) gene / DNA uptake enzyme (ComEC) gene operon, the DNA processing enzyme (DprA) gene, the nuclease (YraN) gene, and the helicase (ComM) gene. As shown in the Examples below, the Tad fimbrial gene operon, the DNA binding enzyme (ComEA) gene / DNA uptake enzyme (ComEC) gene operon, the DNA processing enzyme (DprA) gene, the nuclease (YraN) gene, and the helicase (ComM) gene were all found to be genes whose expression levels correlate with the transformation frequency by the method of the present invention in Bifidobacterium pseudocatenulatum, and their contribution to natural transformation was confirmed by verification using disruptant strains of each gene. The estimated gene product and sequence number of each gene, as well as the estimated function of each operon or gene, are shown in Table 1. The operons or genes carried on the genome of recipient Bifidobacterium bacteria include not only operons or genes consisting of the base sequences shown in the sequence numbers in Table 1, but also operons or genes corresponding thereto. Here, the term "corresponding operon" refers to an operon that encodes a group of proteins having a predetermined function in a certain bacterium, and in another bacterium, the term "corresponding gene" refers to a gene that encodes a protein having the same or similar function as the protein in a certain bacterium, and in another bacterium, and in another bacterium, the term "corresponding gene" refers to a gene that encodes a protein having the same or similar function as the protein in the certain bacterium. An operon and its corresponding operon, or a gene and its corresponding gene, may have the same or different nucleotide sequences, but the identity of the nucleotide sequences between an operon and its corresponding operon, or between a gene and its corresponding gene, is preferably 70% or more, more preferably 80% or more, even more preferably 90% or more, even more preferably 95% or more, and even more preferably 99% or more.
[0022]
[0023] It is preferable to use live Bifidobacterium bacteria in the logarithmic growth phase or stationary phase as the recipient. Live bacteria can be prepared by inoculating a bacterial seed culture into a medium in which the bacteria can grow and culturing it for a predetermined period of time. After culturing, the bacteria may be isolated and purified by centrifugation, filtration, or other suitable means.
[0024] In the method of the present invention, the bacterium used as the donor is not particularly limited as long as it contains the DNA to be introduced into the recipient, and may belong to any genus and species, but is preferably a bacterium belonging to the phylum Actinomycetales, more preferably a bacterium of the order Bifidobacteria, even more preferably a bacterium of the genus Bifidobacterium, and even more preferably a bacterium of the same species as the recipient bacterium of the genus Bifidobacterium. Examples of the species of the donor Bifidobacterium bacterium include the same species as those exemplified above as the recipient Bifidobacterium bacterium.
[0025] The donor bacteria may be live or killed, but killed bacteria are preferred from the viewpoint of ease of handling. It is preferable to use live bacteria in the logarithmic growth phase or stationary phase. Live bacteria can be prepared by inoculating a bacterial seed culture into a medium capable of growth and culturing it for a predetermined period, followed by isolation and purification of the bacterial cells by centrifugation, filtration, or other means. Killed bacteria can be prepared by subjecting live bacteria to heat treatment, alcohol treatment, or the like.
[0026] The DNA contained in the donor bacterium and introduced into the recipient may be DNA from any region of the genome of the bacterium. Preferably, the DNA introduced into the recipient contains a gene. The length of the DNA introduced into the recipient is not particularly limited, but is preferably 3 to 100 kb, more preferably 5 to 30 kb, and even more preferably 10 to 20 kb.
[0027] In the method of the present invention, linear DNA containing the DNA to be introduced into the recipient can also be used as the donor. The linear DNA used as the donor may be isolated from nature, synthesized, or produced using genetic engineering techniques. Examples of linear DNA include PCR products, cDNA, genomic DNA, and fragments thereof, and PCR products are preferably used from the viewpoint of operability.
[0028] The DNA in the linear donor DNA to be introduced into the recipient may be any DNA. In a preferred embodiment, the DNA to be introduced into the recipient contains a gene. In one example, the DNA to be introduced into the recipient is an expression cassette consisting of a promoter, a gene sequence, and a terminator. The expression cassette may contain control regions such as an operator, an enhancer, and a ribosome binding site. In another preferred embodiment, the DNA to be introduced into the recipient contains DNA for introducing a mutation (e.g., deletion, substitution, insertion, or addition) into a target DNA region on the genome of the recipient Bifidobacterium bacterium by substitution with the target DNA region. Such DNA consists of a base sequence in which a portion of the base sequence of the target DNA region has been modified according to the desired mutation. Furthermore, the linear donor DNA may contain various sequences known to those skilled in the art (e.g., restriction enzyme cleavage sites, signal sequences), selection marker genes, etc., as necessary. To facilitate the selection of transformants, it is preferable for the linear DNA to contain a selection marker gene. Examples of selectable marker genes include drug resistance genes such as tetracycline resistance, erythromycin resistance, chloramphenicol resistance, ampicillin resistance, kanamycin resistance, spectinomycin resistance, and streptomycin resistance. Alternatively, when a selective medium is used that requires a specific metabolism for growth, a gene related to that metabolism may be used as a selectable marker. Examples of such metabolism-related genes include a xylanase gene that determines the assimilation of long-chain xylans and an amylase gene that determines the assimilation of starch. These various sequences or elements can be appropriately selected and used by those skilled in the art depending on the conditions, such as the recipient Bifidobacterium bacterium and the culture medium after transformation. The length of the DNA to be introduced into the recipient is not particularly limited, but is preferably 3 to 100 kb, more preferably 5 to 30 kb, and even more preferably 10 to 20 kb.
[0029] In order to control the introduction position or region of the DNA to be introduced into the recipient, the linear DNA as the donor preferably further comprises an upstream homology arm and a downstream homology arm for homologous recombination upstream and downstream of the DNA to be introduced into the recipient. The upstream homology arm consists of a nucleotide sequence homologous to the nucleotide sequence of a region upstream (preferably an adjacent upstream region) of the target DNA introduction position or region on the genome of the Bifidobacterium genus as the recipient, and the downstream homology arm consists of a nucleotide sequence homologous to the nucleotide sequence of a region downstream (preferably an adjacent downstream region) of the target DNA introduction position or region on the genome of the Bifidobacterium genus as the recipient. The identity of the nucleotide sequence of each homology arm to the corresponding region on the genome of the Bifidobacterium genus as the recipient is independently 80% or more, preferably 90% or more, more preferably 95% or more, even more preferably 96% or more, even more preferably 97% or more, even more preferably 98% or more, even more preferably 99% or more, and even more preferably 100%. The length of each homology arm is not particularly limited, but is preferably 0.5 to 5 kb, more preferably 0.8 to 4 kb, and even more preferably 1 to 3 kb, independently, from the viewpoints of homologous recombination efficiency and operability. Such linear DNA as a donor typically comprises, from the 5' side, an upstream homology arm, the DNA to be introduced into the recipient, and the downstream homology arm, and comprises, from the 5' side, the nucleotide sequence of the upstream homology arm, the nucleotide sequence of the DNA to be introduced into the recipient, and the nucleotide sequence of the downstream homology arm. However, as long as the transformation efficiency is not impaired, any nucleotide sequence may be added to at least one position selected from the group consisting of upstream of the nucleotide sequence of the upstream homology arm, between the nucleotide sequence of the upstream homology arm and the nucleotide sequence of the DNA to be introduced into the recipient, between the nucleotide sequence of the DNA to be introduced into the recipient and the nucleotide sequence of the downstream homology arm, and downstream of the nucleotide sequence of the downstream homology arm.
[0030] The medium used in the method of the present invention has a pH of 6.0 or more but less than 10.0, and the content x (mass%) of sugars assimilable by the recipient Bifidobacterium bacterium satisfies the following relationship: 0 < x ≦ 0.2 × (pH) − 1.2 when the pH is 6.0 or more but less than 8.5, and 0.2 × (pH) − 1.7 < x ≦ 0.2 × (pH) − 1.2 when the pH is 8.5 or more but less than 10.0. The medium may be any medium in which the recipient Bifidobacterium bacterium, preferably the recipient Bifidobacterium bacterium and the donor bacterium, can survive well, and other components are not particularly limited as long as the pH and sugar content are within the above-mentioned ranges. The medium may be a solid medium or a liquid medium, but a solid medium is preferred from the viewpoint of transformation efficiency.
[0031] The pH of the medium is 6.0 or higher and lower than 10.0. The pH refers to the pH at 25°C before heat sterilization using an autoclave or the like. From the viewpoint of transformation efficiency, the pH of the medium is preferably 9.5 or lower, more preferably 9.2 or lower. The pH range of the medium is preferably 6.0 to 9.5, more preferably 6.0 to 9.2.
[0032] The medium may contain sugars that can be assimilated by the recipient Bifidobacterium bacteria, preferably the recipient Bifidobacterium bacteria and the donor bacteria, with the content x (mass%) being an amount that satisfies 0 < x ≦ 0.2 × (pH) − 1.2 when the pH is 6.0 or higher but less than 8.5, and 0.2 × (pH) − 1.7 < x ≦ 0.2 × (pH) − 1.2 when the pH is 8.5 or higher but less than 10.0. If the content x (mass%) of sugars that can be assimilated by the recipient Bifidobacterium bacteria is outside this range, good transformation will not occur. Typical examples of such sugars include lactose, glucose, and various oligosaccharides. Typically, media used for culturing Bifidobacterium bacteria (e.g., TOS medium, MRS medium, BL medium) often contain about 1 to 2 mass% of sugars assimilable by Bifidobacterium bacteria, which exceeds the upper limit of the sugar content assimilable by Bifidobacterium bacteria as recipients in the medium of the present invention. Surprisingly, in the present invention, efficient transformation is possible by using a medium with a low content of sugars that may have an adverse effect on the growth of Bifidobacterium bacteria.
[0033] The osmotic pressure of the medium is not particularly limited, but from the viewpoint of transformation efficiency, it is preferably 110 to 750 mOsm, more preferably 120 to 720 mOsm, and even more preferably 130 to 700 mOsm. Here, the osmotic pressure refers to the osmotic pressure of a medium in a state in which the constituent components are dissolved by heating without adding a gelling agent such as agar. The osmotic pressure may be measured by means known in the art, for example, according to the osmotic pressure measurement method (osmolality measurement method) described in the 18th Edition of the Japanese Pharmacopoeia.
[0034] From the viewpoint of transformation efficiency, it is preferable that the medium contains an appropriate amount of MgCl. The MgCl content in the medium is preferably 3 to 180 mM, more preferably 5 to 100 mM.
[0035] The medium used in the method of the present invention may be a commercially available medium, such as Modified GAM Medium (Nissui Pharmaceutical Co., Ltd.) (glucose 0.05% by mass, pH 7.3, osmotic pressure 289 mOsm (actual measured value)) or Cooked Meat Medium (OXOID) (glucose 0.2% by mass, pH 7.2±0.2, osmotic pressure 250 mOsm (actual measured value)).
[0036] The means for contacting the recipient Bifidobacterium bacteria with the donor bacteria or linear DNA is not particularly limited and may be appropriately selected depending on the type of medium, the type of donor, etc. Examples include a method of adding a preculture solution of the donor bacteria or linear DNA to a preculture solution of the recipient Bifidobacterium bacteria, and a method of directly adding, applying, spraying or spraying the donor bacteria or linear DNA to the recipient Bifidobacterium bacteria. In this case, the contacted recipient Bifidobacterium bacteria and donor bacteria or linear DNA may be added to the medium for transformation and subjected to static culture. Alternatively, for example, there may be mentioned a method in which a preculture solution of Bifidobacterium bacteria as the recipient and a preculture solution of bacteria or linear DNA as the donor are both added to the medium for the above-mentioned transformation, or a method in which Bifidobacterium bacteria as the recipient and bacteria or linear DNA as the donor are both added to the medium for the above-mentioned transformation. In this case, the contacted Bifidobacterium bacteria as the recipient and bacteria or linear DNA as the donor may be subjected to static culture as is.
[0037] The bacterial count of the recipient Bifidobacterium bacteria and the bacterial count of the donor bacteria used in the method of the present invention are not particularly limited, but may be independently 10 5 ~10 9 Preferably 10 6 ~10 8The ratio of the bacterial count of the recipient Bifidobacterium bacteria to the bacterial count of the donor bacteria is not particularly limited, but is preferably 1:0.5 to 1.5, more preferably 1:0.8 to 1.2. The amount of linear DNA used as the donor in the method of the present invention is not particularly limited, but is preferably 1:0.5 to 1.5, more preferably 1:0.8 to 1.2, more preferably 1:0.8 to 1.2. The amount of linear DNA used as the donor in the method of the present invention is not particularly limited, but is preferably 1:0.8 to 1.2, more preferably 1:0.8 to 1.2, more preferably 1:0.8 to 1.2. 7 The amount per particle is preferably 0.01 pg to 1000 ng, and more preferably 100 pg to 100 ng.
[0038] Next, the contacted recipient Bifidobacterium bacterium and the donor bacterium or linear DNA are subjected to static culture in the above-mentioned medium for transformation. The culture temperature is 25 to 46°C, preferably 35 to 42°C, and the culture time is 3 to 30 hours, preferably 4 to 24 hours, and more preferably 8 to 16 hours. The culture atmosphere may be aerobic or anaerobic, but anaerobic conditions are preferred.
[0039] The DNA contained in the donor to be introduced into the recipient is introduced into the genome of the recipient by homologous recombination. In particular, when the linear DNA serving as the donor contains an upstream homology arm and a downstream homology arm in addition to the DNA to be introduced into the recipient, the DNA contained in the linear DNA to be introduced into the recipient is introduced into the target DNA introduction position or region on the genome of the recipient Bifidobacterium by homologous recombination. Thus, the method of the present invention enables manipulation of the genome of the recipient Bifidobacterium. From the results of gene expression analysis of Bifidobacterium bacteria used as recipients shown in the Examples below, it is speculated that donor-derived DNA is introduced from the donor to the recipient via the following mechanism: recipient pili capture donor DNA outside the cell; the captured DNA is converted into single strands by the action of an enzyme that converts double-stranded DNA to single strands; a DNA uptake enzyme transports the single-stranded DNA into the cell; a single-stranded DNA-binding protein recognizes the single-stranded DNA and calls in a recombinase; and homologous recombination occurs in the recipient genome.
[0040] The transformant of interest obtained by the method of the present invention can be obtained by a method appropriate for the DNA introduced. Examples include a method in which the bacterial cells after static culture are appropriately cultured in a medium in which the transformant of interest can survive, and clones in which the introduction of DNA has been confirmed by PCR are selected as the transformant of interest from the resulting clones; a method in which the bacterial cells after static culture are appropriately cultured in a medium in which the transformant of interest can survive, and clones into which the DNA has been introduced are selected as the transformant of interest by genome analysis from the resulting clones; and a method in which the bacterial cells after static culture are appropriately cultured in a selective medium containing a drug corresponding to the selection marker, and clones obtained are selected as the transformant of interest. Here, the bacterial cells after static culture may be cultured under normal culture conditions for Bifidobacterium bacteria. That is, various conditions, such as the inoculum amount, temperature, time, and culture atmosphere, suitable for the Bifidobacterium bacteria inoculated into the medium may be appropriately set. For example, the inoculation amount may be 0.01 to 5%, preferably 0.1 to 1%, the culture temperature may be 25 to 46°C, preferably 35 to 42°C, and the culture time may be 6 to 120 hours, preferably 24 to 72 hours. The culture atmosphere may be aerobic or anaerobic, but anaerobic conditions are preferred.
[0041] The method of the present invention makes it possible to efficiently enhance the expression of a target gene in a bacterium of the genus Bifidobacterium. Examples of techniques for enhancing the expression of a target gene include a method of increasing the copy number of the target gene by introducing the target gene into the genome of a bacterium of the genus Bifidobacterium using the method of the present invention, and a method of modifying the regulatory region or regulatory gene of the target gene in the genome of a bacterium of the genus Bifidobacterium using the method of the present invention to increase the amount of transcription into mRNA.
[0042] Furthermore, the method of the present invention makes it possible to efficiently inhibit or suppress the expression of a target gene in a Bifidobacterium bacterium. Examples of techniques for inhibiting the expression of a target gene include inserting an entirely different DNA into the target gene on the genome of a recipient Bifidobacterium bacterium using the method of the present invention, and deleting part or all of the target gene on the genome of a recipient Bifidobacterium bacterium using the method of the present invention. Examples of techniques for suppressing the expression of a target gene include modifying the regulatory region or regulatory gene of the target gene on the genome of a recipient Bifidobacterium bacterium using the method of the present invention to reduce the amount of transcription to mRNA.
[0043] Furthermore, the method of the present invention enables genome manipulation of Bifidobacterium bacteria using as a recipient a Bifidobacterium bacterium that does not have the upp gene encoding uracil phosphoribosyltransferase (UPRTase) and as a donor a linear DNA comprising an upstream homology arm, two genes (a selection marker gene and the upp gene), and a downstream homology arm, wherein the two genes are located between the upstream and downstream homology arms and the 3'-terminal region of the upstream homology arm is contained between the two genes and the downstream homology arm, or the 5'-terminal region of the downstream homology arm is contained between the upstream and downstream homology arms. In this case, the two genes, the selection marker gene and the upp gene, correspond to the DNA to be introduced into the recipient. That is, the method for genome manipulation of Bifidobacterium bacteria of the present invention comprises contacting Bifidobacterium bacteria as a recipient with linear DNA as a donor and statically culturing the bacteria, wherein the medium used for the static culturing has a pH of 6.0 or higher and lower than 10.0, and the content x (mass %) of sugars assimilable by the Bifidobacterium bacteria as the recipient satisfies 0<x≦0.2×(pH)−1.2 when the pH is 6.0 or higher and lower than 8.5, and 0.2×(pH)−1.7<x≦0.2×(pH)−1.2 when the pH is 8.5 or higher and lower than 10.0, and the donor linear DNA comprises an upstream homology arm, two genes, a selection marker gene and an upp gene, and a downstream homology arm, the two genes being arranged between the upstream homology arm and the downstream homology arm, and the 3'-terminal region of the upstream homology arm is included between the two genes and the downstream homology arm, or the 5'-terminal region of the downstream homology arm is included between the upstream homology arm and the two genes.
[0044] Here, the selection marker gene is a positive selection marker for selecting (positive selection) strains into which two genes, the selection marker gene and the upp gene, have been introduced, and the above-mentioned drug resistance gene or metabolism-related gene is preferably used. On the other hand, the upp gene is a negative selection marker for selecting (negative selection) strains from which the two genes, the selection marker gene and the upp gene, have been deleted. UPRTase encoded by the upp gene converts 5-fluorouracil (5FU) to 5-fluorouridine monophosphate, which is ultimately converted to 5-fluoro-dUMP. Because 5-fluoro-dUMP is a toxic metabolic product, strains lacking the upp gene do not die in the presence of 5FU, whereas strains containing the upp gene die in the presence of 5FU. Therefore, in the presence of 5FU, the upp gene functions as a lethal negative selection marker. The nucleotide sequence of the upp gene of Bifidobacterium pseudocatenulatum is shown in SEQ ID NO: 13. In the present invention, the upp gene includes not only the gene consisting of the nucleotide sequence shown in SEQ ID NO: 13, but also genes corresponding thereto. Here, "corresponding gene" refers to a gene that encodes a protein having the same or similar function as UPRTase in a certain bacterium. The upp gene consisting of the nucleotide sequence shown in SEQ ID NO: 13 and the gene corresponding thereto may have the same nucleotide sequence or different nucleotide sequences, but the identity of the nucleotide sequences is preferably 70% or more, more preferably 80% or more, even more preferably 90% or more, even more preferably 95% or more, and even more preferably 99% or more.
[0045] In the linear DNA used as a donor, the selectable marker gene and the upp gene may be linked directly or via another base sequence, as long as they are linked in an expressible manner, and the order in which the genes are linked is not particularly limited. Preferably, the linear DNA used as a donor contains an expression cassette for the selectable marker gene consisting of a promoter, the base sequence of the selectable marker gene, and a terminator, and an expression cassette for the upp gene consisting of a promoter, the base sequence of the upp gene, and a terminator. The expression cassette may contain control regions such as an operator, an enhancer, and a ribosome binding site.
[0046] The linear DNA used as the donor comprises an upstream homology arm, two types of genes, a selection marker gene and an upp gene (hereinafter collectively referred to as a marker gene group), and a downstream homology arm. The upstream homology arm comprises a base sequence homologous to the base sequence of a region upstream of the target DNA introduction site or region on the genome of the recipient Bifidobacterium (preferably an adjacent upstream region), and the downstream homology arm comprises a base sequence homologous to the base sequence of a region downstream of the target DNA introduction site or region on the genome of the recipient Bifidobacterium (preferably an adjacent downstream region). In the linear DNA used as the donor, the marker gene group is located between the upstream homology arm and the downstream homology arm, and the 3'-terminal region of the upstream homology arm is included as a direct repeat between the marker gene group and the downstream homology arm, or the 5'-terminal region of the downstream homology arm is included as a direct repeat between the upstream homology arm and the marker gene group. The identity of the base sequence of each homology arm to the corresponding region on the genome of the recipient Bifidobacterium bacterium is independently at least 80%, preferably 90% or more, more preferably 95% or more, even more preferably 96% or more, even more preferably 97% or more, even more preferably 98% or more, even more preferably 99% or more, and even more preferably 100%. The length of each homology arm is not particularly limited, but from the viewpoint of homologous recombination efficiency, it is preferably 0.5 to 5 kb, more preferably 0.8 to 4 kb, and even more preferably 1 to 3 kb. The length of the direct repeat is not particularly limited, but from the viewpoint of homologous recombination efficiency, it is preferably 15 to 100 bp, more preferably 30 to 70 bp, and even more preferably 45 to 60 bp.Such linear DNA as a donor typically comprises, from the 5' side, an upstream homology arm, a marker gene group, a direct repeat, and a downstream homology arm; and from the 5' side, the nucleotide sequence of the upstream homology arm, the nucleotide sequence of the marker gene group, the nucleotide sequence of the direct repeat, and the nucleotide sequence of the downstream homology arm; or comprises, from the 5' side, an upstream homology arm, a direct repeat, a marker gene group, and a downstream homology arm; and from the 5' side, the nucleotide sequence of the upstream homology arm, the nucleotide sequence of the direct repeat, the nucleotide sequence of the marker gene group, and the nucleotide sequence of the downstream homology arm; however, as long as the transformation efficiency is not impaired, any nucleotide sequence may be added to at least one position selected from the group consisting of upstream of the upstream homology arm, between the upstream homology arm and the marker gene group, between the marker gene group and the direct repeat, and downstream of the downstream homology arm; or at least one position selected from the group consisting of upstream of the upstream homology arm, between the direct repeat and the marker gene group, between the marker gene group and the downstream homology arm, and downstream of the downstream homology arm.
[0047] Bifidobacterium bacteria as recipients to be subjected to genome manipulation do not have an upp gene. Therefore, the donor-derived upp gene introduced into the recipient can function as a negative selection marker. Bifidobacterium bacteria that do not have an upp gene may be Bifidobacterium bacteria that do not have an endogenous upp gene, or may be Bifidobacterium bacteria in which the upp gene has been disrupted (e.g., deleted) by the transformation method of the present invention or a known method. Examples of species of Bifidobacterium bacteria include those similar to those described above.
[0048] In the method for genome manipulation of Bifidobacterium bacteria of the present invention, the means for contacting the recipient Bifidobacterium bacteria with the donor linear DNA, the amount of recipient Bifidobacterium bacteria, the amount of donor linear DNA, the medium, and the mode of static culture are the same as in the method for transformation of Bifidobacterium bacteria of the present invention.
[0049] The marker gene group contained in the donor is introduced by homologous recombination into the target DNA introduction site or region on the genome of the recipient Bifidobacterium bacterium. A transformant into which the marker gene group has been introduced can be obtained by a method appropriate for the type of selection marker gene (positive selection). For example, the bacterial cells after static culture are appropriately cultured in a selective medium supplemented with a drug corresponding to the selection marker, and the resulting clone is selected as the desired transformant. The transformant into which the marker gene group has been introduced is then cultured in a 5FU-containing medium, whereby homologous recombination occurs between the direct repeats, resulting in the loss of the marker gene group from the genome, thereby obtaining the desired transformant capable of growing in the 5FU-containing medium (negative selection). Therefore, the genome manipulation method for Bifidobacterium bacteria of the present invention may further include selecting transformants into which the marker gene group has been introduced using the functional expression of the selection marker (e.g., antibiotic resistance) as an indicator, and selecting from the selected transformants transformants from which the marker gene group has been lost using sensitivity to 5FU as an indicator. The 5FU concentration in the 5FU-containing medium is preferably 50 to 500 mM, more preferably 50 to 200 mM. The bacterial cells may be cultured under normal culture conditions for Bifidobacterium bacteria.
[0050] The genome manipulation method for Bifidobacterium bacteria of the present invention enables markerless genome manipulation, which modifies the genome of Bifidobacterium bacteria without leaving traces of marker genes. Examples of genome manipulation include deletion, substitution, and insertion. For example, deletion can be achieved by using linear DNA comprising an upstream homology arm, a marker gene group, and a downstream homology arm, with the marker gene group positioned between the upstream homology arm and the downstream homology arm, and containing the 3'-terminal region of the upstream homology arm as a direct repeat between the marker gene group and the downstream homology arm, or containing the 5'-terminal region of the downstream homology arm as a direct repeat between the upstream homology arm and the marker gene group. In this case, a target DNA region in the genome of the recipient Bifidobacterium bacteria is deleted. The length of the target DNA region to be deleted is not particularly limited, but is preferably 1 to 10,000 bp, more preferably 1 to 6,000 bp, and even more preferably 1 to 4,000 bp. Furthermore, for example, in the case of substitution or insertion, linear DNA may be used that includes an upstream homology arm, a marker gene group, and a downstream homology arm, the marker gene group being located between the upstream homology arm and the downstream homology arm, and that includes the 3'-terminal region of the upstream homology arm as a direct repeat between the marker gene group and the downstream homology arm, or that includes the 5'-terminal region of the downstream homology arm as a direct repeat between the upstream homology arm and the marker gene group, and further includes the desired sequence to be inserted or replaced between the direct repeat and the downstream homology arm, or that includes the desired sequence to be inserted or replaced between the upstream homology arm and the direct repeat. In this case, the desired sequence is inserted into the target DNA position on the genome of the recipient Bifidobacterium bacterium, or the target DNA region on the genome of the recipient Bifidobacterium bacterium is replaced with the desired sequence. The length of the DNA region to be inserted or the target DNA region to be replaced is not particularly limited, but is preferably 1 to 10,000 bp, more preferably 1 to 6,000 bp, and even more preferably 1 to 4,000 bp.
[0051] The genome manipulation kit for Bifidobacterium bacteria is a kit for performing genome manipulation of Bifidobacterium bacteria according to the genome manipulation method of Bifidobacterium bacteria of the present invention. The kit of the present invention contains a medium having a pH of 6.0 or more and less than 10.0, and a content x (mass %) of sugars assimilable by the recipient Bifidobacterium bacteria that satisfies the following relationship: 0 < x ≦ 0.2 × (pH) − 1.2 when the pH is 6.0 or more and less than 8.5, and 0.2 × (pH) − 1.7 < x ≦ 0.2 × (pH) − 1.2 when the pH is 8.5 or more and less than 10.0, and linear DNA comprising a selection marker gene and an upp gene. The linear DNA preferably comprises an upstream homology arm, two genes, a selectable marker gene and an upp gene, and a downstream homology arm, the two genes being arranged between the upstream homology arm and the downstream homology arm, and the 3'-terminal region of the upstream homology arm being between the two genes and the downstream homology arm, or the 5'-terminal region of the downstream homology arm being between the upstream homology arm and the two genes. The kit may also comprise guidance for carrying out the genome manipulation method of Bifidobacterium of the present invention.
[0052] As shown in the Examples below, by the transformation method of the present invention, Bifidobacterium pseudocatenulatum YIT 11057 (NITE BP-02930), which has the ability to utilize glucose, was used as a parent strain and bred by UV irradiation and long-term subculture. As a result, Bifidobacterium pseudocatenulatum Y 51493 (NITE ABP-03852), which has better viability in milk medium than the parent strain but has lost the ability to utilize glucose, was used as a recipient and the genomic DNA of YIT 11057 as a donor to restore the single-base deletion in the gene (SEQ ID NO: 14) encoding the glucose transporter, which was the cause of the loss of glucose assimilation ability, to obtain Bifidobacterium pseudocatenulatum YIT 13179 (NITE ABP-03853), which has the ability to utilize glucose while maintaining excellent viability in milk medium. YIT 13179 was deposited on March 13, 2023, at the Patent Microorganisms Depositary of the National Institute of Technology and Evaluation (Room 122, 2-5-8 Kazusa Kamatari, Kisarazu City, Chiba Prefecture, Japan). Here, glucose assimilation refers to the ability to grow using glucose as a carbon source. Bifidobacterium species are known to be difficult to artificially manipulate genetically, and single-base deletions are difficult to restore using conventional UV irradiation or long-term subculture. However, the method of the present invention makes it possible to restore even single-base deletions.
[0053] The form of use of the Bifidobacterium bacteria obtained by the method of the present invention is not particularly limited, and they may be freeze-dried or used as a culture containing these bacteria. In either form, it is preferable that the bacteria are in a live state.
[0054] The Bifidobacterium bacteria obtained by the method of the present invention can be used in the form of conventional pharmaceutical preparations by mixing with a solid or liquid non-toxic pharmaceutical carrier. Examples of such preparations include solid preparations such as tablets, granules, powders, and capsules; liquid preparations such as solutions, suspensions, and emulsions; and lyophilized preparations. These preparations can be prepared by conventional pharmaceutical techniques. Examples of such non-toxic pharmaceutical carriers include glucose, lactose, sucrose, starch, mannitol, dextrin, fatty acid glycerides, polyethylene glycol, hydroxyethyl starch, ethylene glycol, polyoxyethylene sorbitan fatty acid esters, amino acids, gelatin, albumin, water, and physiological saline. Conventional additives such as stabilizers, humectants, emulsifiers, binders, isotonicity agents, and excipients can also be added as needed.
[0055] The Bifidobacterium bacteria obtained by the method of the present invention can be used not only in the formulations described above, but also by being incorporated into foods and beverages. When incorporated into foods and beverages, they may be contained as they are or together with various nutritional components. Specifically, when incorporating the Bifidobacterium bacteria obtained by the method of the present invention into foods and beverages, additives that can be used in foods and beverages may be appropriately used, and the bacteria may be formed into edible forms, such as granules, particles, tablets, capsules, pastes, etc., using conventional means. They may also be added to various foods, such as processed meat foods such as ham and sausage, processed seafood foods such as kamaboko and chikuwa, bread, confectionery, butter, powdered milk, or beverages such as water, fruit juice, milk, soft drinks, and tea drinks. Incidentally, animal feeds are also included in foods and beverages.
[0056] Furthermore, suitable foods and beverages include fermented milk foods and beverages, such as fermented soy milk, fermented fruit juice, and fermented vegetable juice, containing live Bifidobacterium bacteria obtained by the method of the present invention. Fermented milk foods and beverages are particularly preferred. Fermented milk foods and beverages can be produced according to conventional methods. For example, when producing fermented milk, Bifidobacterium bacteria obtained by the method of the present invention are inoculated and cultured in a sterilized milk medium, either alone or together with other microorganisms, and then homogenized to obtain a fermented milk base. A separately prepared syrup solution is then added and mixed, homogenized using a homogenizer, or the like, and a flavor is added to produce the final product. The fermented milk foods and beverages obtained in this manner can be in any form, such as a plain type (without syrup (sweetener)), soft type, fruit-flavored type, solid, or liquid.
[0057] Such fermented milk foods and drinks can contain optional ingredients such as sweeteners such as syrups, emulsifiers, thickeners (stabilizers), various vitamins, etc. Examples of syrups include sugars such as glucose, sucrose, fructose, high-fructose corn syrup, high-fructose corn syrup, palatinose, trehalose, lactose, xylose, galactooligosaccharides (GOS), xylooligosaccharides (XOS), arabinoxylooligosaccharides (AXOS), xylan, arabinoxylan, arabinooligosaccharides (AOS), arabinan, maltose, honey, and molasses; sorbitol, xylitol, erythritol, lactitol, palatinit, reduced starch syrup, and reduced maltose water. The sweetener may contain sugar alcohols such as candy, high-intensity sweeteners such as aspartame, thaumatin, sucralose, acesulfame K, and stevia, emulsifiers such as glycerin fatty acid esters, polyglycerin fatty acid esters, sorbitan fatty acid esters, and lecithin, and thickeners (stabilizers) such as agar, gelatin, carrageenan, guar gum, xanthan gum, pectin, locust bean gum, gellan gum, carboxymethylcellulose, soybean polysaccharides, and propylene glycol alginate. Other ingredients that can be added include vitamins such as vitamin A, B vitamins, vitamin C, and vitamin E; minerals such as calcium, magnesium, zinc, iron, and manganese; acidulants such as citric acid, lactic acid, acetic acid, malic acid, tartaric acid, and gluconic acid; milk fats such as cream, butter, and sour cream; flavors such as yogurt, berry, orange, quince, perilla, citrus, apple, mint, grape, apricot, pear, custard cream, peach, melon, banana, tropical, herbal, black tea, and coffee; herbal extracts; and brown sugar extracts.
[0058] In the production of fermented milk foods and drinks, it is also possible to use microorganisms other than the Bifidobacterium bacteria obtained by the method of the present invention in combination. Examples of such microorganisms include Lacticaseibacillus bacteria such as Lacticaseibacillus paracasei, Lactobacillus casei, and the like. casei), Lactobacillus acidophilus (L. acidophilus), Lactobacillus plantarum (L. plantarum), Lactobacillus buchneri (L. buchneri), Lactobacillus gallinarum (L. gallinarum), Lactobacillus amylovorus (L. amylovorus), Lactobacillus brevis (L. brevis), Lactobacillus rhamnosus (L. rhamnosus), Lactobacillus kefir (L. kefir), Lactobacillus Lactobacillus paracasei (L. paracasei), Lactobacillus crispatus (L. crispatus), Lactobacillus zeae (L. zeae), Lactobacillus helveticus (L. helveticus), Lactobacillus salivarius (L. salivarius), Lactobacillus gasseri (L. gasseri), Lactobacillus fermentum (L. fermentum), Lactobacillus reuteri (L. reuteri), Lactobacillus delbrueckii subsp. bulgaricus (L. delbrueckii subsp. bulgaricus), Lactobacillus delbrueckii subsp. Lactobacillus bacteria such as L. delbrueckii subsp. delbrueckii and L. johnsonii, Streptococcus bacteria such as Streptococcus thermophilus, Lactococcus lactis subsp. lactis and Lactococcus lactis subsp. lactis. Lactococcus bacteria such as Lactococcus lactis subsp. cremoris, Enterococcus faecalis,Examples of the bacteria include bacteria of the genus Enterococcus such as Enterococcus faecium (E. faecium), bacteria of the genus Bacillus such as Bacillus subtilis, and yeasts belonging to the genera Saccharomyces, Torulaspora, and Candida such as Saccharomyces cerevisiae, Torulaspora delbrueckii, and Candida kefir.
[0059] Although there is no strict limit to the dosage of the Bifidobacterium bacteria obtained by the method of the present invention, a suitable dosage is 10 viable bacteria per day. 5 ~10 13 cfu, especially 10 8 ~10 12 cfu is preferred.
[0060] The present invention will now be described in more detail with reference to examples, but the present invention is not limited to these examples in any way.
[0061] Example 1: Discovery of genome mosaicism in Bifidobacterium bacteria. Analysis of the assimilation of indigestible polysaccharides and genome analysis using strains belonging to Bifidobacterium pseudocatenulatum revealed that some strains exhibit long-chain xylan assimilation, which is determined by the xylanase (BpXyn10A) gene present in the chromosome. Furthermore, when strains carrying the xylanase gene are plotted on a phylogenetic tree constructed based on the genome information of Bifidobacterium pseudocatenulatum strains, they are not concentrated in a specific cluster but are dispersed throughout the tree (Non-Patent Document 1). This suggests that xylanase genes are horizontally transferred between strains. Therefore, horizontal transfer of xylanase genes was investigated in vitro. Generally, horizontal gene transfer in bacteria is known to occur in three ways: natural transformation via the uptake of extracellular DNA, transduction via phage infection, and conjugation via the transfer of plasmids, etc. Therefore, to detect any phenomena, two phenotypically different strains of Bifidobacterium pseudocatenulatum were cultured individually and then co-cultured on agar medium for a certain period of time to verify horizontal gene transfer.
[0062] (1) Strains Used: Donor strains of Bifidobacterium pseudocatenulatum (YIT 11025, YIT 11027, YIT 12242, YIT 12820, YIT 12824, YIT 12986) have a xylanase gene and are sensitive to tetracycline (Tc), and donor strains of Bifidobacterium pseudocatenulatum (YIT 4072) do not have a xylanase gene and are Tc-resistant. T , YIT 11955, YIT 11956, YIT 12228, YIT 12818, YIT 12822, and YIT 12987) were used as recipients.
[0063] (2) Method for verifying horizontal transfer of xylanase gene The donor and recipient strains were inoculated into modified GAM (mGAM) liquid medium (Nissui Pharmaceutical Co., Ltd.) supplemented with 0.5% by mass of glucose and lactose and cultured until the logarithmic growth phase. 200 μL of the donor and recipient bacterial solutions were mixed (bacterial count: approximately 10 8-9After centrifugation, the supernatant was removed using a 200 μL pipette. The pellet was suspended using the small amount of medium remaining in the tube, and the entire amount was placed on mGAM agar medium (Nissui Pharmaceutical Co., Ltd.). After anaerobic culture at 37°C for 16 to 24 hours, the cells were scraped using a 1 μL loop and inoculated into mPY-AX-Tc (mPY medium: see Non-Patent Document 1, arabinoxylan (AX): final concentration 0.5% by mass, Tc: final concentration 10 μg / mL) liquid medium, which cannot grow as a donor or recipient alone. Turbidity was monitored using Eon Microplate Spectrophotometers (Biotech). Some combinations that showed an increase in turbidity in the selective medium were subcultured in fresh medium to confirm the reproducibility of the increase in turbidity. This bacterial solution was smeared on mGAM agar medium containing Tc (final concentration 10 μg / mL) and cultured anaerobically overnight at 37°C, and the resulting single colonies were subcultured on the same agar medium. The next day, a portion of the bacterial cells was inoculated into mPY-AX-Tc liquid medium, and another portion was suspended in TE buffer and heated at 95°C for 5 minutes to serve as a simple template for PCR. Growth in mPY-AX-Tc medium was examined, and when the recipient was YIT 11956, strain identification and the presence or absence of the gene were confirmed by PCR using recipient (YIT 11956)-specific primers (BP28-f: GGGCAAGATCGGCATCATCTA (SEQ ID NO: 15), BP28-r: CACATTGGTGGTGTTCACGTC (SEQ ID NO: 16)) and xylanase gene-specific primers (pBpXyn10A-F: CGAGAATGCGAACACGTACTTC (SEQ ID NO: 17), pBpXyn10A-R: CTGCTCGGTGTTGTAATCGTTG (SEQ ID NO: 18)). Colonies in which the presence of the xylanase gene was confirmed were frozen and stored.
[0064] (3) Genome analysis method DNA was extracted from the bacterial cells obtained in (2), and short-read and long-read sequences were obtained using a second-generation sequencer, Miseq (Illumina Inc.), and a third-generation sequencer, MinION (Oxford Nanopore Technologies). Hybrid assembly was performed to obtain the full-length genome sequence. The genome sequences of the donor strain, recipient strain, and gene acquisition strain were aligned using snippy (https: / / github.com / tseemann / snippy), and the alignment results were entered into fastGEAR (Mostowy et al., Molecular Biology and Evolution 34(5), 1167-1182) to identify homologous recombination regions. In addition, single nucleotide polymorphism (SNP) information was extracted from the genome sequence using nucmer, delta-filter, and show-snps from the MUMMER (Kurtz et al., Genome Biology 5, R12, 2004) package, and after adjusting the format of the output file with a custom script, homologous recombination regions were visualized using Artemis ACT (Sanger Institute).
[0065] (4) Verification results of horizontal xylanase gene transfer After mixing the donor and recipient, they were anaerobically cultured overnight on mGAM agar medium, and then inoculated into mPY-AX-Tc liquid selective medium to monitor growth. As a result, an increase in turbidity was observed in several donor-recipient combinations. Among them, YIT 11956 and YIT 4072 T Genome analysis of the 13 gene-acquired strains obtained using YIT11025, YIT11027, YIT12820, or YIT12824 as the recipient and YIT11025, YIT11027, YIT12820, or YIT12824 as the donor revealed that all of the gene-acquired strains possessed the xylanase gene and were closely related to the recipients rather than the donors. It was also revealed that the xylanase gene on the chromosome had been transmitted from the donor strain, which possessed the xylanase gene, to the recipient strain, which did not possess the same gene (Fig. 1, Table 2). It was confirmed that the strains into which the xylanase gene had been transmitted could grow in mPY-AX medium (Fig. 2).
[0066] Detailed comparison of genome sequences at the SNP level revealed that the SNPs in the gene-acquired strains matched those of the donor strain in the newly acquired xylanase gene, as well as in the 16.5-247 kb region including the upstream and downstream regions. This suggests that the gene-acquired strains experienced extensive double-crossover homologous recombination, resulting in the replacement of the donor-derived genomic region, including the xylanase gene and its upstream and downstream regions, resulting in horizontal transfer of the xylanase gene. Furthermore, the replacement of genomic regions occurred in a mosaic pattern across the genome, and the replacement regions varied among strains. Specifically, the donor-derived genomic region was integrated at up to seven locations per strain, spanning a region of 0.5-247 kb (Figure 1). However, no traces of phage or plasmid were found in the replacement regions.
[0067] To verify the generality of this phenomenon, we also attempted to verify the horizontal transfer of other genes possessed by Bifidobacterium pseudocatenulatum. First, we focused on the amylase gene, which determines starch assimilation. A Bifidobacterium pseudocatenulatum strain (YIT 11027) possessing the amylase gene and sensitive to Tc was used as the donor, and a Bifidobacterium pseudocatenulatum strain (YIT 11956) lacking the amylase gene and resistant to Tc was used as the recipient. Using a method similar to that described in (2), the bacterial cells after mixing of each strain were inoculated into an mPY-St-Tc liquid medium (starch (St): final concentration 0.5% by mass, Tc: final concentration 10 μg / mL). We confirmed that the genome became mosaic and that strains with horizontally transferred amylase genes appeared (Table 2). It was confirmed that the strain into which the amylase gene was transferred could grow in mPY-Starch medium (Figure 3). Furthermore, we also focused on the Tc resistance gene. A Bifidobacterium pseudocatenulatum strain (YIT 4072) that possessed the Tc resistance gene and was sensitive to erythromycin (Em) was identified. TThe donors were B. pseudocatenulatum strains YIT 11955, YIT 12987, and a B. pseudocatenulatum strain (YIT 12824) lacking the Tc resistance gene and resistant to Em was used as the recipient. Using the same method as in (2), the mixed strains were smeared on modified GAM (mGAML) agar medium supplemented with 0.5% lactose by weight and Em (final concentration 1 μg / mL) and Tc (final concentration 10 μg / mL). This confirmed the emergence of strains with horizontally transferred Tc resistance genes due to genome mosaicism (Table 2). It was confirmed that the strains with the transferred Tc resistance gene could grow on Tc-mGAML medium (Figure 4).
[0068]
[0069] Example 2 Verification of natural transformation in Bifidobacterium bacteria Since no trace of horizontal transfer of phages or plasmids was observed in the mosaic genome of Bifidobacterium bacteria, it was verified whether this was due to natural transformation.
[0070] (1) Strain used: YIT 4072, a Tc-resistant and Em-sensitive type strain of Bifidobacterium pseudocatenulatum T was used as a donor, and Tc-sensitive and Em-resistant Bifidobacterium pseudocatenulatum YIT 12824 was used as a recipient.
[0071] (2) Method for extracting genomic DNA to be used as a donor and preparing PCR products YIT 4072 TThe cells were cultured overnight in mGAML liquid medium, and high-molecular-weight genomic DNA was purified using NucleoBond Buffer Set III and a NucleoBond AXG20 column (Takara Bio Inc.). The amount of double-stranded DNA was quantified using a Picogreen kit and diluted with TE buffer to 30 ng / μL. Furthermore, using this genomic DNA as a template, a region of approximately 20 kb containing the Tc resistance gene (tetW) was amplified by PCR. The high-fidelity enzyme PrimeSTAR GXL DNA polymerase (Takara Bio Inc.) was used as the PCR enzyme. 0.2 μL of enzyme, 0.04 μL each of 50 μM primers (SEQ ID NOs: 19 and 20), 1 μL of template DNA (0.02 ng / μL), 1.6 μL of dNTP solution, and 4 μL of 5x buffer were mixed to a reaction volume of 20 μL per PCR tube. The resulting PCR product was precipitated with ethanol and dissolved in TE buffer. Double-stranded DNA was quantified using Picogreen, then diluted with TE buffer to 1 ng / μL, aliquoted, and stored frozen. The primers and PCR conditions used in this example are shown in Table 3.
[0072]
[0073] (3) Method for preparing killed bacterial cells YIT 4072 T The cells were cultured in 2 mL of mGAML liquid medium until the late logarithmic growth phase, washed with mPY liquid medium, and the pellet was suspended in 180 μL of the same medium. 20 μL of the culture was dispensed into a 1.5 mL screw-cap tube and heated at 80°C for 10 minutes using a heat block to prepare killed cells. It was separately confirmed that the cells were completely killed by this treatment.
[0074] (4) Verification of horizontal transfer of antibiotic resistance genes using live, heat-killed, and purified DNA donors YIT 4072 TFrozen cells of each strain, YIT 12824, were inoculated onto mGAML agar medium and cultured anaerobically at 37°C. The resulting cells were then subcultured in 400 μL of the same liquid medium. After culturing for 3 to 4 hours, 1600 μL of the same liquid medium was added and cultured for 4 to 5 hours until the late logarithmic growth phase was reached and the cells reached the stationary phase. The cells were collected from each liquid and washed with mPY liquid medium, then collected again and suspended in 180 μL of the same medium. 5 μL of the recipient (YIT 12824) liquid and 5 μL of the donor (YIT 4072) liquid were cultured. T ) and 5 μL of the live cell suspension prepared in (3) or the killed cell suspension prepared in (2) were mixed (each with a cell count of approximately 10 7-8 The entire amount of the culture was placed on mGAM agar medium. After anaerobic culture at 37°C for 16 to 24 hours, the entire amount of cells was scraped using a 1 μL loop and suspended in 60 μL of mPY liquid medium. The resulting mixture was serially diluted and smeared on EmTc-mGAML agar medium, and cultured anaerobically at 37°C for 2 to 3 days, after which the number of colonies was counted. Genomic analysis was performed on some of the colonies in the same manner as in Example 1(3), and it was confirmed that homologous recombination had occurred.
[0075] (5) Verification of the effect of adding DNA decomposition enzyme (DNase I) As in (4), YIT 4072 TWashed live bacterial solutions of YIT 12824 and YIT 12824 were prepared. 20 μL of the washed bacterial solution was dispensed into 1.5 mL tubes, mixed, and centrifuged. The pellet was suspended in 40 μL of 1x DNase I buffer (Takara Bio Inc.). 8 μL of undiluted solution (5 U / μL) or Recombinant DNase I (Takara Bio Inc.) diluted 1 / 10 (0.5 U / μL) or 3 / 10 (1.5 U / μL) with 1x DNase I buffer was added. 12 μL of each solution was placed on mGAM agar medium, three times per condition. The agar medium on which the bacterial cells were placed was anaerobically cultured at 37°C for 16 hours, after which the entire volume of bacterial cells was scraped off with a 1 μL loop, suspended in 60 μL of mPY liquid medium, and then appropriately diluted with the same medium. To measure the number of bacteria that had horizontally transferred the Tc resistance gene, the bacterial suspension was spread on EmTc-mGAML agar medium. To detect the total viable number of Em-resistant strains, the bacterial suspension was also spread on Em-mGAML agar medium. Each agar medium was anaerobically cultured at 37°C for 2-3 days, and the ratio of mosaic-forming bacteria to the total viable number of Em-resistant strains was used as the mosaic frequency.
[0076] (6) Results Donor YIT 4072 TLive cells of the donor strain YIT 12824 (a Tc-resistant strain) were mixed with the recipient strain YIT 12824 (an Em-resistant strain) and then cultured anaerobically overnight on mGAM agar medium. The emergence of both resistant strains was examined on selective media, where growth of the donor and recipient strains alone was impossible. Colonies resistant to both antibiotics emerged. Genomic analysis of the six strains confirmed mosaic homologous recombination events in multiple regions, including the Tc resistance gene and its neighboring regions. The number of recombination regions ranged from one to four, with the maximum length ranging from 22 to 112 kb. Horizontal transfer of the Tc resistance gene was confirmed when killed cells were used as the donor, although at a lower frequency than when live cells were used (Figure 5A). Similarly, horizontal transfer also occurred when the donor was replaced with genomic DNA or a PCR product (Figure 5B). When killed bacteria were used as donors, the number of recombination regions was 1-2 and the maximum length of the recombination region was 16-45 kb in the two strains whose genomes were analyzed. When genomic DNA was used as donors, the number of recombination regions was 1 and the maximum length of the recombination region was 12-16 kb in the two strains whose genomes were analyzed. T When PCR products prepared using the genomic DNA of YIT 4072 as a template were used, the number of recombination regions was 1 and the maximum recombination region length was 12 kb in one strain whose genome was analyzed. Furthermore, when DNase was added to a test system using live cells as a donor, horizontal gene transfer was inhibited (Figure 5C). Therefore, it was revealed that the route of genome mosaicism accompanying horizontal gene transfer in Bifidobacterium bacteria is natural transformation through the incorporation of extracellular DNA and homologous recombination. Therefore, the above-mentioned mosaicism frequency (Frequency) means the transformation frequency. As a result of confirming the universality of natural transformation in Bifidobacterium pseudocatenulatum, YIT 4072 T Using PCR products prepared using the genomic DNA of the strain as a template as donors, horizontal transfer of the Tc resistance gene was confirmed in 11 new strains (Table 4).
[0077]
[0078] Example 3: Searching for Factors Affecting the Transformation Frequency of Bifidobacterium The incorporation of foreign DNA into bacteria through natural transformation is thought to increase genome diversity and contribute to bacterial adaptation to their environment. On the other hand, excessive natural transformation may disrupt the genome structure that has evolved over a long period of time and may actually be detrimental to the bacteria. Therefore, in many bacterial species for which natural transformation has been reported, natural transformation is strictly controlled and occurs only under specific environmental conditions. Therefore, in order to efficiently transform Bifidobacterium bacteria, we investigated the conditions under which natural transformation occurs.
[0079] (1) Strain Used Tc-sensitive Bifidobacterium pseudocatenulatum YIT 12819 (GenBank accession number: GCA_020526245.1) was used as the recipient.
[0080] (2) Preparation of donor DNA First, we created YIT 12819, which had a Tc resistance gene inserted into an intergenic region of the chromosome. Using the genomic DNA of this strain as a template, we amplified approximately 20 kb of donor DNA containing the Tc resistance gene and approximately 10 kb of homology arms upstream and downstream of it by PCR.
[0081] (i) Creation of a Tc resistance gene-inserted strain YIT 4072 T A construct for inserting the Tc resistance gene (tetW) of YIT 12819 into the intergenic region of YIT 12819 was prepared by PCR. A high-fidelity DNA polymerase, KOD-Plus-Neo (Toyobo Co., Ltd.), was used for all PCRs, and the final concentration of primers was 0.3 μM. The upstream homologous region (upstream homology arm) of the insertion construct was amplified by PCR using the YIT 12819 genomic DNA as a template and the primers of SEQ ID NOs: 21 and 22. The downstream homologous region (downstream homology arm) of the insertion construct was amplified by PCR using the YIT 12819 genomic DNA as a template and the primers of SEQ ID NOs: 25 and 26. The Tc resistance gene region was amplified by PCR using the YIT 4072 genomic DNA as a template and the primers of SEQ ID NOs: 26. TThe genomic DNA of the strain was used as a template and amplified by PCR using primers of SEQ ID NOs: 23 and 24. Agarose gel electrophoresis was performed, and the band of interest was excised. DNA was then extracted from the gel using a Freeze 'N' Squeeze spin column (BIO-RAD). The concentration differences between the fragments were visually confirmed by agarose gel electrophoresis, and the fragments were mixed to achieve approximately equal concentrations. The fragments were then ligated by overlap extension PCR (OE-PCR) using primers of SEQ ID NOs: 21 and 26. After confirming that the desired amplification product had been obtained by electrophoresis, the band of interest was extracted from the gel and precipitated with ethanol. The resulting DNA was dissolved in TE buffer. This DNA solution and YIT 12819 (bacterial count: approximately 10 7 The resulting mixture was placed on mGAM agar medium supplemented with 50 mM magnesium chloride and anaerobically cultured at 37°C for 16 hours to carry out transformation. The next day, the cells were smeared on mGAML agar medium containing Tc (final concentration 10 μg / mL) to obtain a strain with the Tc resistance gene inserted.
[0082] (ii) Preparation of PCR Fragment Using the genomic DNA of YIT 12819 into which the Tc resistance gene had been inserted as a template, a PCR fragment of approximately 20 kb containing the Tc resistance gene was prepared. PrimeSTAR GXL DNA polymerase was used as the PCR enzyme. Primers of SEQ ID NOs: 27 and 28 were used to amplify the fragment. The desired amplified product was confirmed by electrophoresis, and then ethanol precipitation was performed. The double-stranded DNA concentration was quantified using Picogreen, and the solution was adjusted to 1 ng / μL using TE buffer, aliquoted, and stored frozen at -30°C. The primers and PCR conditions used in this example are shown in Table 5.
[0083]
[0084] (3) Transformation Method Frozen cells of YIT 12819 were inoculated onto mGAML agar medium and cultured anaerobically at 37°C in a glove box. The resulting cells were then subcultured in 400 μL of mGAML liquid medium. After culturing for 3 to 4 hours, 1600 μL of the same liquid medium was added and cultured for 3 to 4 hours until the late logarithmic growth phase reached the stationary phase. The cells were collected from the cell suspension, washed with mPY liquid medium, and then collected again and suspended in 180 to 220 μL of the same medium to prepare a cell suspension for transformation. The cell suspension (cell count: approximately 10 7-8 Equal volumes of the donor DNA (1) and (2) were mixed and placed in five 10 μL aliquots on the various agar media listed below (N=5). After 16 hours of anaerobic culture at 37°C, the entire volume of the bacteria was scraped off with a 1 μL loop and suspended in 60 μL of mPY liquid medium. The culture was appropriately diluted with the same medium and smeared on Tc-containing mGAML agar medium to measure the CFU of the transformant, and on Tc-free mGAML agar medium to measure the total CFU. The ratio of CFU of the transformant to the total CFU was used as the frequency of transformation.
[0085] (4) Media Used (i) pH-Changed Media mGAM liquid medium was prepared and its pH was measured (the actual measured value before adjustment was pH 7.0). After adjusting the pH from 5.5 to 8.5 in 0.5 intervals by adding hydrochloric acid or sodium hydroxide, Bacto Agar (final concentration 1.5%) was added and the mixture was sterilized in an autoclave. The mixture was then dispensed into petri dishes and dried in a safety cabinet for 1 to 1.5 hours. (ii) Media supplemented with various salts and sugars mGAM agar medium (pH 7.0) was supplemented with sodium chloride (50, 100, 200 mM), potassium chloride (50 mM), ammonium chloride (50 mM), magnesium chloride (5, 20, 50, 100, 200 mM), or lactose (2.5, 5.0, 50 mM, corresponding to approximately 0.086, 0.17, and 1.71% by mass, respectively) (all final concentrations), autoclaved, dispensed into Petri dishes, and dried in a safety cabinet for 1 to 1.5 hours. Note that mGAM medium originally contains 0.05% by mass of glucose, so the readily decomposable sugar content of the medium is the total content of glucose and lactose, which is approximately 0.136, 0.22, and 1.76% by mass, respectively. Furthermore, mGAM agar medium also contains 0.5% by mass of soluble starch, but since the YIT 12819 used in this experiment does not assimilate soluble starch, soluble starch is not considered a readily degradable sugar in this experiment. (iii) pH-adjusted and sugar-supplemented medium mGAM liquid medium was prepared, and sodium hydroxide was added to adjust the pH from 7 to 10 in 1-point increments. Lactose (final concentrations: 0, 0.25, 0.50, 0.75, 1.00% by mass) and Bacto Agar (final concentration: 1.5%) were then added, followed by autoclave sterilization. The medium was then dispensed into Petri dishes and allowed to dry in a safety cabinet for 1 to 1.5 hours. (iv) Osmolarity-Adjusted Medium Sodium chloride (final concentrations of 0, 25, 50, 75, 100, 125, 150, and 200 mM; the measured osmolarity values for each were 65, 102, 134, 211, 417, 593, 681, and 761 mOsm) was added to modified trypticase soy agar medium (trypticase 1.5% by mass, soybean peptone 0.05% by mass, and Bacto Agar 1.5% by mass) (pH 7.0), sterilized in an autoclave, dispensed into petri dishes, and dried in a safety cabinet for 1 to 1.5 hours.(v) Commercially Available Media Modified GAM agar medium (Nissui Pharmaceutical), MRS agar medium (BD Difco), TOS propionic acid agar medium (Yakult Pharmaceutical Industry), trypticase soy agar medium (BD BBL), and cooked meat agar medium (OXOID) (added with Bacto Agar at a final concentration of 1.5%) were prepared.
[0086] (5) Results Transformation was performed by varying the pH of mGAM agar medium, and the pH of the medium affected the transformation frequency (Figure 6A). Transformation occurred at pH 6.0 to 8.5, with the transformation frequency maximal at pH 6.5 and significantly reduced at pH 6.0. This indicates that an acidic environment inhibits transformation. Furthermore, sugar (lactose), which bifidobacteria can easily decompose, inhibited transformation in a dose-dependent manner (Figure 6B). The inhibition of transformation by sugar is thought to be due to the acid produced by sugar metabolism lowering the pH around the bacterial cells. Therefore, it was predicted that the inhibitory effect of sugar addition would be reduced in an alkaline medium. Verification confirmed that transformation occurred even in the presence of larger amounts of sugar by making the medium alkaline (Figure 6C). Collectively, the relationship between the pH of the medium at which transformation occurred and the amount of added sugar was expressed by the following mathematical formula (Figure 6C). When the pH was between 6.0 and 10.0 and the sugar content x (mass%) was 0 < x ≤ 0.2 × (pH) - 1.2 when the pH was between 6.0 and 8.5, and 0.2 × (pH) - 1.7 < x ≤ 0.2 × (pH) - 1.2 when the pH was between 8.5 and 10.0. Furthermore, various salts were found to affect transformation frequency (Figure 6D). Moderate concentrations of sodium chloride, potassium chloride, ammonium chloride, or magnesium chloride promoted transformation. Magnesium chloride was highly promoted at concentrations of 5 to 100 mM (Figure 6E). For salts other than magnesium chloride, the frequency of natural transformation was nearly the same when added at the same amount, suggesting that the osmotic pressure of the medium may play a role. To verify this, we measured the frequency of natural transformation using medium whose osmolality was adjusted with sodium chloride. Spontaneous transformation occurred in media with osmolality ranging from 134 to 681 mOsm, but not in media with osmolality below 102 mOsm or 761 mOsm (Figure 6F). Furthermore, the transformation frequency peaked around 417 mOsm. Therefore, we found that osmolality influences transformation. Next, we examined the effect of gelling agents in the medium.Natural transformation frequencies were measured in mGAM agar medium and mGAM liquid medium (static culture and rotary shaking culture at 10 rpm). Among these three conditions, natural transformation occurred most efficiently in agar medium, while natural transformation rarely occurred in liquid medium cultured with rotary shaking (Figure 6G). Finally, we examined whether natural transformation occurred using commercially available media (Figure 6H). In addition to mGAM agar medium, natural transformation also occurred in cooked meat medium (CM) and trypticase soy agar medium (TS). The osmotic pressure, pH, and readily degradable sugar content of both media were within the above-mentioned ranges. On the other hand, natural transformation did not occur in TOS propionic acid agar medium (containing 1% by weight of galactooligosaccharides) or MRS agar medium (containing 2% by weight of dextrose), which are commonly used for culturing bifidobacteria. Because both media contain large amounts of readily degradable sugars, it is believed that transformation was suppressed by a decrease in pH due to acid production. In this study, the transformation frequency was highest when 50 mM magnesium chloride was added to the mGAM agar medium, and the efficiency of obtaining transformants in this case was 2.5 × 10 per μg of donor DNA. 8 This figure is the maximum reported efficiency for obtaining transformants of bifidobacteria using a plasmid (3.8 × 10 6 cells / μg DNA: 65.7 times higher than that of non-patent document 4).
[0087] Example 4: Establishment of a markerless genome manipulation system for Bifidobacterium bacteria. Example 3(2)(i) demonstrated that a drug resistance gene could be inserted at any position in the recipient genome using Bifidobacterium pseudocatenulatum as the recipient and linear DNA as the donor. Therefore, it was expected that a similar procedure could be used to disrupt any target gene by replacing it with a drug resistance (marker) gene contained in linear DNA. On the other hand, gene disruption methods using marker gene replacement make it difficult to achieve multiple disruption. Therefore, it is desirable to establish a markerless genome manipulation system that allows for free editing of target regions without leaving traces of marker genes in the genome. A typical markerless genome manipulation system consists of two steps: introduction of a construct using a positive selection marker (positive selection) and removal of unnecessary sequences using a negative selection marker (negative selection). As shown in Examples 2 and 3, positive selection is possible using the transformation method of the present invention, so we searched for negative selection markers and investigated a markerless genome manipulation system.
[0088] (1) Strain Used Tc-sensitive Bifidobacterium pseudocatenulatum YIT 12819 was used as the recipient.
[0089] (2) Confirmation of 5-fluorouracil susceptibility. YIT 12819 was cultured in mGAML liquid medium in an anaerobic glove box until the late logarithmic growth phase. Then, 50 μL of the undiluted culture solution and a 10-fold dilution were smeared onto mGAML agar medium supplemented with 5-fluorouracil (5FU) (final concentration: 100 μg / mL) and cultured anaerobically. The culture solution was also appropriately diluted and smeared onto mGAML agar medium to measure the total bacterial count in the culture solution. The percentage of 5FU-resistant bacteria among the total bacterial count was defined as the incidence of 5FU-resistant colonies.
[0090] (3) Preparation of an upp deletion construct The upstream and downstream regions of the upp gene encoding uracil phosphoribosyltransferase (UPRTase) of YIT 12819 were linked by OE-PCR to prepare an upp deletion construct. KOD-Plus-Neo was used as the PCR enzyme. The upstream region was amplified by PCR using YIT 12819 genomic DNA as a template and primers set forth in SEQ ID NOs: 29 and 30. The downstream region was amplified by PCR using YIT 12819 genomic DNA as a template and primers set forth in SEQ ID NOs: 31 and 32. Each fragment was extracted from the gel after agarose gel electrophoresis and mixed to approximately equal concentrations. This mixture was used as a template for OE-PCR using primers set forth in SEQ ID NOs: 29 and 32. After agarose gel electrophoresis, the target band was extracted from the gel. Finally, ethanol precipitation was performed, and the DNA was dissolved in TE buffer and used in the following tests. The DNA contains, from the 5' end, an upstream homology arm consisting of a base sequence homologous to the upstream region of the upp gene and a downstream homology arm consisting of a base sequence homologous to the downstream region of the upp gene. The primers and PCR conditions used in this example are shown in Table 6.
[0091]
[0092] (4) Creation of an upp deletion strain Frozen cells of YIT 12819 were inoculated onto mGAML agar medium and cultured anaerobically, and the resulting colonies were subcultured in 400 μL of the same liquid medium. After culturing for 3 to 4 hours, 1600 μL of the same liquid medium was added and cultured for 4 to 5 hours until the late logarithmic growth phase. After centrifugation, the cell pellet was washed once with 1 mL of mPY liquid medium and suspended in 200 μL of the same liquid medium. The bacterial solution and an equal volume of the DNA solution for the upp deletion construct in (3) were mixed (5 μL each, approximately 10 cells). 7-810 μL of the mixture was gently spotted onto 50 mM magnesium chloride-supplemented mGAM agar medium using a 10 μL pipette. The mixture was left to dry for several minutes, and then anaerobically cultured at 37°C for 16 hours. The next day, the entire volume of bacteria was scraped with a 1 μL loop and suspended in 60 μL of mPY liquid medium. The bacteria were then smeared on mGAML agar medium supplemented with 5FU (final concentration 100 μg / mL) and cultured at 37°C. The next day, the resulting colonies were subcultured on the same agar medium, and a portion was suspended in TE buffer and heated at 95°C for 5 minutes to serve as a PCR template. To confirm the presence or absence of upp, real-time PCR was performed using upp gene detection primers (139q-f: CGATCATTGTGCCTGTGCTG (SEQ ID NO: 33), 139q-r: TGATCTGCTGGGTTGGGTTC (SEQ ID NO: 34)) and an ABI7500. For strains in which the upp gene was not detected, PCR was performed using primers for confirming the deletion site (upp-del-check-f: GACAATTCCAAGTGGGGTTC (SEQ ID NO: 35), upp-del-check-r: GTCGCGGAAAACTGGAGTAA (SEQ ID NO: 36)). The fragment length of the PCR product was confirmed by agarose gel electrophoresis, and it was confirmed that a fragment of the expected size (879 bp) was obtained in the deletion strain. Furthermore, sequencing was performed by the Sanger method using this PCR product as a template to confirm the absence of unintended base sequence mutations, and an upp deletion strain (YIT 12819 Δupp) was obtained.
[0093] (5) Preparation of upp-tetW cassette A construct was prepared to insert the Tc resistance gene (tetW) into the intergenic region downstream of the upp gene of YIT 12819. KOD-Plus-Neo was used as the PCR enzyme. The upstream homology arm was amplified by PCR using the genomic DNA of YIT 12819 as a template and the primers of SEQ ID NOs: 37 and 38. The downstream homology arm was amplified by PCR using the genomic DNA of YIT 12819 as a template and the primers of SEQ ID NOs: 41 and 42. The Tc resistance gene region was amplified by PCR using the genomic DNA of YIT 4072 TThe genomic DNA of this construct was used as a template and amplified by PCR using primers of SEQ ID NOs: 39 and 40. Each fragment was extracted from the gel after agarose gel electrophoresis and mixed to approximately equal concentrations. This mixture was used as a template for OE-PCR using primers of SEQ ID NOs: 37 and 42. After agarose gel electrophoresis, the target band was extracted from the gel. Finally, ethanol precipitation was performed, and the DNA was dissolved in TE buffer. The DNA contained, from the 5' end, an upstream homology arm consisting of a nucleotide sequence homologous to the region immediately upstream of the upp gene, the upp gene, the tetW gene, and a downstream homology arm consisting of a nucleotide sequence homologous to the region immediately downstream of the upp gene. Transformation was performed in the same manner as in (4) except that YIT 12819 and this construct were used. The cells were plated on mGAML agar medium supplemented with Tc (final concentration 10 μg / mL), and Tc-resistant colonies were isolated. Using the genomic DNA of the colony as a template, a region containing the putative promoter sequence of the upp gene and the putative terminator sequence of the tetW gene was amplified by PCR using primers of SEQ ID NOs: 43 and 44 to prepare an upp-tetW cassette. The primers and PCR conditions used in this example are shown in Table 7.
[0094]
[0095] (6) Preparation of target gene deletion construct. The YIT12819_00675-677 gene of YIT12819 was used as the target gene. The upstream and downstream regions of this gene in the YIT12819 genome were linked to the upp-tetW cassette (5) by OE-PCR to prepare a target gene deletion construct. KOD-Plus-Neo was used as the PCR enzyme. The upstream region was amplified by PCR using YIT12819 genomic DNA as a template and primers with SEQ ID NOs: 45 and 46. The downstream region was amplified by PCR using YIT12819 genomic DNA as a template and primers with SEQ ID NOs: 47 and 48. In this case, the nucleotide sequence of the region adjacent to the upp-tetW cassette in the downstream region was inserted as a direct repeat into the upstream region and adjacent to the cassette. Each fragment was extracted from the gel after agarose gel electrophoresis. OE-PCR was performed using primers of SEQ ID NOs: 45 and 44, with a mixture of fragments of the downstream region and upp-tetW cassette at approximately equal concentrations as a template. After agarose gel electrophoresis, the target band was extracted from the gel, and the resulting fragment was mixed with a fragment of the upstream region at approximately equal concentrations. OE-PCR was performed using primers of SEQ ID NOs: 45 and 48 as a template. After agarose gel electrophoresis, the target band was extracted from the gel. Finally, ethanol precipitation was performed, and the DNA was dissolved in TE buffer and used in the following tests. The DNA contained, from the 5' end, an upstream homology arm (containing a direct repeat in the 3'-terminal region) consisting of a nucleotide sequence homologous to the upstream region of the target gene, the upp gene, the tetW gene, the direct repeat, and a downstream homology arm consisting of a nucleotide sequence homologous to the downstream region of the target gene. The primers and PCR conditions used in this example are shown in Table 8.
[0096]
[0097] (7) Creation of target gene deletion strains. Transformation was performed in the same manner as in (4), except that YIT 12819 Δupp and the target gene deletion construct described in (6) were used. The cells were plated on Tc-supplemented mGAML agar medium, and the resulting colonies were replica-passaged onto Tc-supplemented mGAML agar medium and 5FU-supplemented mGAML agar medium. Several Tc-resistant and 5FU-sensitive colonies were selected, suspended in TE buffer, and heated at 95°C for 5 minutes to serve as a PCR template. Primers for detecting the upp gene (SEQ ID NOs: 33 and 34), primers for detecting the tetW gene (tetW-f: TCGCTGTCCCCGGAAATAGTC (SEQ ID NO: 49), tetW-r: CTGTCACCGCATCCATCAACG (SEQ ID NO: 50)), primers for detecting YIT 12189_00675 (675q-f: CATCCTGGCCGAAAGCAATC (SEQ ID NO: 51), 675q-r: GGTGATGTTGCCATGCTGTG (SEQ ID NO: 52)), primers for detecting YIT 12189_00676 (676q-f: CGCATGACTGCTTGAACGAC (SEQ ID NO: 53), 676q-r: CTTGCATACGCCTTGATCGC (SEQ ID NO: 54)), primers for detecting YIT 12189_00677 (677q-f: CGCATGGCTGGAAAGACAAG (SEQ ID NO: 55), 677q-r: The presence or absence of the upp gene, tetW gene, and target gene was confirmed by real-time PCR using CGCCTGGTTTTGACTTCGAC (SEQ ID NO: 56), and strains in which the tetW gene and upp gene had been inserted and the target gene had been deleted were selected. Each colony was inoculated into mGAML liquid medium and cultured until the late logarithmic growth phase, after which 50 μL of the bacterial solution was smeared on 5FU-supplemented mGAML agar medium. The colonies obtained the next day were replica-passaged onto Tc-supplemented mGAML agar medium and 5FU-supplemented mGAML agar medium, and Tc-sensitive and 5FU-resistant colonies were selected. The bacterial cells were suspended in TE buffer and heated at 95°C for 5 minutes, and PCR was performed using this as a template to confirm the presence or absence of the upp gene, tetW gene, and target gene. For strains in which all genes were not detected, the nucleotide sequence of the recombination site was determined by the Sanger method.
[0098] (8) Results We focused on the 5FU / upp system (Fabret et al., Mol. Microbiol. 46(1)25-36, 2002), which has been reported to function as a negative selection marker in Bacillus subtilis and other bacteria. This system utilizes the property of UPRTase, encoded by the upp gene, to convert 5FU, a uracil analog, into 5-fluorouridine monophosphate, ultimately producing a toxic metabolite (5-fluoro-dUMP), which kills the bacteria. In other words, strains lacking the upp gene do not die in the presence of 5FU, while the exogenous upp gene is expected to function as a lethal negative selection marker. For the 5FU / upp system to function, it is necessary that bacteria containing the upp gene exhibit lethality in 5FU-supplemented medium. Genome analysis confirmed that YIT 12819 contains the upp gene. Subsequently, a culture of YIT 12819 was plated on a 5FU-supplemented agar medium to a bacterial count of 1.6 x 10 8 or 1.6 x 10 7 As a result of CFU smear, the number of 5FU-resistant bacteria was as low as 10 or 8 CFU, and most of the bacteria were killed. The frequency of 5FU-resistant colonies was 6.5 x 10 -7 or 4.9 x 10 -7 This was lower than that of Bacillus subtilis, in which the 5FU / upp system is functional. This suggests that the 5FU / upp system also functions as a negative selection marker in Bifidobacterium bacteria.
[0099] Using YIT 12819 Δupp and the upp-tetW cassette, we attempted to create a strain lacking the target gene (the YIT 12819_00675-677 gene cluster) using the transformation method of the present invention. A schematic diagram of this example is shown in Figure 7. Positive selection of colonies with the upp-tetW cassette inserted allowed us to obtain a strain in which the target gene had been replaced with the upp-tetW cassette. These results demonstrated that natural transformation can be used to disrupt any target gene by replacing it with a drug resistance (marker) gene contained in linear DNA. The upp-tetW cassette-replaced strain was then plated on 5FU-supplemented medium, and recombination occurred between the direct repeats, resulting in a strain lacking the target gene and exhibiting 5FU resistance. These findings demonstrate the feasibility of genome manipulation using the transformation method of the present invention in combination with the 5FU / upp system.
[0100] Example 5 Identification of transformation-related genes in Bifidobacterium pseudocatenulatum (1) RNAseq mGAM agar media were prepared under conditions in which the transformation clarified in Example 3 was promoted (addition of magnesium chloride (final concentration 50 mM) and osmotic pressure adjustment (final concentration of non-assimilable sugar fucose and final concentration of 50 mM sodium acetate)) or suppressed (pH 6.0, pH 9.0). Two YIT 12819 bacterial solutions mixed with the DNA donor of Example 3(2) were placed on each agar medium and anaerobically cultured overnight. After confirming that the frequency of transformation in each medium was promoted or suppressed as expected, RNAseq was performed to comprehensively analyze the gene expression levels. Total RNA was extracted by the hot phenol method. DNA was digested using DNase I, followed by PCI treatment and ethanol precipitation. The resulting RNA was dissolved in Nuclease-Free Water. RNA purity was confirmed using a Bioanalyzer 2100 and RNA 6000 Nano LabChip kit (Agilent Technologies, Inc.), and the RIN value for all samples was confirmed to be 9-10. rRNA was removed using QIAseq FastSelect-5S / 16S / 23S (Qiagen), and a cDNA library was prepared using QIAseq Stranded RNA Lib Kit (Qiagen). Sequencing was performed using Miseq and Miseq Reagent V3 Kit (150 cycles) (Illumina, Inc.), and 75-bp paired-end data was obtained. After quality control using fastp (Chen et al., Bioinformatics 34(17), i884-i890), rRNA sequences were removed using SortMeRNA (Kopylova et al., Bioinformatics28(24), 3211-3217).Reads were mapped to the genome sequence of YIT 12819 using Bowtie2 (Langmead et al., Nature Methods 9, 357-359), and the number of reads mapped to each gene was calculated using featureCounts (Liao et al., Bioinformatics 30(7), 923-930). After calculating TPM, we searched for genes whose expression levels correlated with transformation frequency.
[0101] (2) Creation of gene deletion strains Using the markerless genome manipulation method of Example 4, deletion strains for each of the genes found in (1) were created. The primers and PCR conditions used to create the deletion strains are shown in Tables 9-1 and 9-2. After amplifying the upstream and downstream regions of each gene by PCR, constructs were prepared by linking each fragment and the upp-tetW cassette by OE-PCR. Deletion strains for each gene were created using the genome manipulation method described in Example 4.
[0102]
[0103]
[0104] (3) Measurement of transformation frequency in gene deletion strains The transformation frequency in each gene deletion strain was measured according to Example 3(3).
[0105] (4) Results A search for genes associated with the frequency of transformation and their expression levels revealed several gene clusters. Using a markerless genome manipulation system, we created deletion strains for each gene and examined their effects on transformation frequency. As a result, we identified the Tad fimbria gene operon (YIT 12189_00143-00149), the DNA binding enzyme (ComEA) gene / DNA uptake enzyme (ComEC) gene operon (YIT 12189_00905-00906), the DNA processing enzyme (DprA) gene (YIT 12189_00675), the nuclease (YraN) gene (YIT 12189_00677), and the helicase (ComM) gene (YIT 12189_00676) as genes whose deletion completely inhibited transformation (Table 10). These genes were identified as transformation-related genes. The predicted function of each gene was in good agreement with the molecular model of natural transformation in Gram-positive bacteria (Johnston, Calum, Bernard Martin, Gwennaele Fichant, Patrice Polard, and Jean-Pierre Claverys. 2014. Nature Reviews Microbiology 12(3):181-96.). The amino acid sequences of the proteins encoded by the identified genes all shared approximately 30% identity with proteins found in bacterial species in which natural transformation has been confirmed. This indicates that function is conserved even with this level of amino acid identity.
[0106]
[0107] From the above results, it is speculated that donor-derived DNA is introduced from the donor to the recipient Bifidobacterium bacterium through the following mechanism: recipient pili capture donor DNA outside the bacterial cell; the captured DNA is converted to single strands by the action of an enzyme that converts double-stranded DNA to single strands; a DNA uptake enzyme transports the single-stranded DNA into the bacterial cell; a single-stranded DNA-binding protein recognizes the single-stranded DNA and calls in a recombinase; a helicase dissociates the double-stranded DNA in the genome; and homologous recombination occurs in the recipient genome.
[0108] Example 6 Distribution of Genes in Bifidobacterium The distribution of the genes shown in Table 10 above in the major human-resident Bifidobacterium species was analyzed. The genomes of 486 strains of five major human-resident Bifidobacterium species (Table 11) were downloaded from public databases, and homologs of the genes shown in Table 10 above (sequences satisfying evalue<1e-10 in a BLASTP search using the amino acid sequence as a query) were searched for, and the proportion of strains possessing homologs for each species was calculated. The results for essential genes are shown in Table 12. It was revealed that almost all species and strains possess homologs of genes other than YIT 12819_00148.
[0109]
[0110]
[0111] Example 7 Verification of transformation of bacteria of the genus Bifidobacterium Whether transformation also occurs in two bacterial species other than Bifidobacterium pseudocatenulatum (Bifidobacterium breve and Bifidobacterium longum) was verified.
[0112] (1) Strains Used For testing Bifidobacterium breve, an Em-resistant strain (BR-Cw104-C2 strain) and an Em-sensitive strain (BR-Cw104-A1 strain) were used. For testing Bifidobacterium longum, a galactan-utilizing, Em-sensitive strain (YIT 12762) and a galactan-nonutilizing, Em-resistant strain (YIT 12812) were used. For testing between different bacterial species, Em-resistant Bifidobacterium longum (LO-Cw098-B4 strain) and Em-sensitive Bifidobacterium breve (BR-Cw104-A1 strain) were used.
[0113] (2) Transformation For Bifidobacterium breve, heat-killed cells of an Em-resistant strain (BR-Cw104-C2 strain) were prepared using the same procedure as in Example 2(3). Using the heat-killed cells as the donor and the Em-sensitive strain (BR-Cw104-A1 strain) as the recipient, transformation was performed in the same manner as in Example 2(4), and the cells were smeared on mGAML (Em-mGAML) agar medium supplemented with Em (1 μg / mL). After obtaining single colonies, genome analysis of the resulting transformants was performed in the same manner as in Example 1(3).
[0114] Bifidobacterium longum was transformed using live YIT 12762 cells and live YIT 12812 cells in the same manner as in Example 2(4), and the transformed cells were inoculated into mPY medium (PY-galactan-erythromycin medium) containing galactan (final concentration 0.5%) and Em (1 μg / mL). The bacterial solution in which growth was observed on the second day was again subcultured at 1% in fresh medium. After another two days, the bacterial solution in which growth was observed was subcultured at 1% in the same medium. The next day, the grown bacterial solution was streaked on mGAM agar medium supplemented with Em, and single colonies were obtained. Genome analysis of the transformants obtained in this manner was performed in the same manner as in Example 1(3).
[0115] For the combination of Bifidobacterium longum and Bifidobacterium breve, transformation was performed in the same manner as in Example 2(3) using heat-killed cells of an Em-resistant strain of Bifidobacterium longum (LO-Cw098-B4 strain) as the donor and an Em-sensitive strain of Bifidobacterium longum (BR-Cw104-A1 strain) as the recipient, and the transformation was carried out in the same manner as in Example 2(4). The transformation was then smeared on mGAML (Em-mGAML) agar medium supplemented with Em (1 μg / mL). After obtaining single colonies, genome analysis of the resulting transformants was carried out in the same manner as in Example 1(3).
[0116] (3) Results We confirmed that transformation occurred in Bifidobacterium breve, and that the Em resistance gene on the donor chromosome was transmitted to the recipient ( Figure 8A ). We confirmed that the strain to which the Em resistance gene was transmitted could grow in Em-mGAML medium ( Figure 9A ). Similarly, we confirmed that transformation occurred in Bifidobacterium longum, and that the Em resistance gene on the donor chromosome was transmitted to the recipient ( Figure 8B ). We confirmed that the strain to which the Em resistance gene was transmitted could grow in Em-mGAML medium ( Figure 9B ). We also confirmed that transformation occurred when Bifidobacterium longum was used as the donor and Bifidobacterium breve was used as the recipient, and that the Em resistance gene on the donor chromosome was transmitted to the recipient ( Figure 8C ). We confirmed that the strain to which the Em resistance gene was transmitted could grow in Em-mGAML medium ( Figure 9C ). These results demonstrate that transformation can occur not only between homologous species but also between heterologous species. These results demonstrate that transformation actually occurs in bacterial species that conserve the genes listed in Table 10. Furthermore, transformation also occurred in Bifidobacterium longum that does not contain YIT12189_00148 ( FIG. 8B ), demonstrating that Tad pili can be formed and transformation can occur even without this gene.
[0117] Example 8 Restoration of Glucose Assimilability by Transformation of Bifidobacterium Bifidobacterium pseudocatenulatum YIT 11057 is a novel probiotic candidate strain that is expected to actively metabolize sugars in the intestine and produce organic acids. Considering its use in fermented milk production, YIT 11057 was bred by UV irradiation and long-term subculture to enhance its survival in milk medium, resulting in Bifidobacterium pseudocatenulatum Y 51493, which has improved survival in milk medium. However, Y 51493 had lost its glucose assimilation ability during the breeding process. Genome analysis revealed that Y51493 had a single C base deletion at position 369 of the gene (SEQ ID NO: 14) encoding the glucose transporter (beta-glucoside PTS system EIICBA component), which resulted in a frameshift and a significant change in the amino acid sequence, presumably resulting in the inability to transport glucose into cells. From the perspective of sugar metabolism in the intestine, maintaining glucose assimilation is desirable. However, restoring the base deletion by conventional UV irradiation or long-term subculture is unrealistic. Therefore, using Y51493 as the parent strain, i.e., recipient, glucose assimilation was restored by breeding using the transformation method of the present invention.
[0118] (1) Strain Used Bifidobacterium pseudocatenulatum Y51493 was used as the recipient.
[0119] (2) Donor DNA Genomic DNA was extracted by the bead phenol method from 1 mL of a bacterial solution obtained by culturing YIT 11057 overnight in mGAML liquid medium.
[0120] (3) Transformation and Selection of Bacteria with Restored Glucose Utilization Ability All procedures were performed in an anaerobic glove box. Frozen cells of Y51493 were inoculated onto mGAML agar medium and cultured anaerobically overnight. The following morning, multiple colonies were simultaneously scraped and subcultured in 400 μL of the same liquid medium. After 3–4 hours of culture, 1600 μL of the same liquid medium was added and cultured for 4–5 hours. After centrifugation, the cell pellet was washed once with 500 μL of mPY liquid medium and suspended in 180 μL of the same liquid medium. The bacterial suspension was mixed with an equal volume of DNA solution (YIT11057 genomic DNA dissolved in TE buffer after ethanol precipitation), and 10 μL of the mixture was spotted onto mGAM agar medium supplemented with 50 mM magnesium chloride. The mixture was left to dry for several minutes and then cultured anaerobically at 37°C. The agar medium was autoclaved on the day of use. After 16 hours, the entire bacterial pellet was scraped with a 1 μL loop and suspended in 500 μL of mPY liquid medium. A 50 μL aliquot was removed and suspended in 640 μL of 0.5% glucose-supplemented mPY liquid medium. 200 μL of this was placed in a 96-well plate, overlaid with 50 μL of mineral oil, and a growth curve was obtained using a PowerWave 340 microplate reader (Biotech). The remaining bacterial solution was anaerobically cultured at 37°C in a 1.5 mL tube. When an increase in turbidity was confirmed on the PC screen, 10 μL of the bacterial solution from the 1.5 mL tube was subcultured in 500 μL of fresh liquid medium, and the mixture was divided into a 96-well plate and a 1.5 mL tube, and growth was monitored again. If growth was confirmed after that, the bacterial solution in the 1.5 mL tube was streaked onto mGAML agar medium, and single colonies were isolated, suspended in glycerol, and stored at -80°C. The isolated strain cells were suspended in mPY liquid medium supplemented with 0.5% glucose, and growth was confirmed. The full-length genome of the isolated strain was determined using the procedure described in Example 1 (3).
[0121] (4) Glucose utilization test: The frozen bacterial suspension of the isolated strain obtained in (3) was inoculated onto mGAML agar medium and cultured overnight. The resulting colonies were scraped off and inoculated into mGAML liquid medium for pre-culture. After 5 to 6 hours, the OD 600 100 μL of the remaining bacterial solution was centrifuged, the supernatant was removed, and the OD600 The cells were suspended in mPY medium so that the β-actin concentration was 0.2. 198 μL of mPY medium supplemented with 0.5% glucose was dispensed into a 96-well plate, 2 μL of the bacterial solution was added, and then 50 μL of mineral oil was overlaid. The cells were cultured at 37°C in a PowerWave 340 to obtain a growth curve.
[0122] (5) Analysis of Mutation Sites Using the full-length genome of YIT 11057 as a reference, mutations occurring in the strains obtained in (3) were examined. First, SNPs were identified using snippy. Furthermore, large-scale genomic changes and SNPs not detected by snippy were visually confirmed using mauve (Darling et al., Genome Research 14, 1394-1403).
[0123] (6) Results Transformation was performed using DNA extracted from YIT 11057 as the donor and live cells of Y51493 as the recipient, resulting in the transformant Bifidobacterium pseudocatenulatum YIT 13179, which grew in a liquid medium containing glucose as the sole sugar source. The glucose assimilation ability of YIT 13179 was confirmed to be glucose assimilation ( FIG. 10 ). The full-length genome of YIT 13179 was determined, and the nucleotide sequence of the glucose transporter gene was confirmed. The single-nucleotide deletion in Y51493 was restored in YIT 13179, and the full-length gene sequence was identical to that of YIT 11057.
[0124] During the breeding process from YIT 11057 to Y 51493, mutations were introduced at 15 sites in the genome, which are expected to contribute to improved viability in milk culture. Of these, only one site in YIT 13179 was restored to the YIT 11057 sequence. The restored mutation was a deletion in a glucose transporter gene.
[0125] The above results demonstrate that the transformation method of the present invention makes it possible to easily obtain even strains in which a single base deletion has been restored, which is difficult to obtain by conventional breeding methods.
Claims
1. A method for transforming Bifidobacterium bacteria, comprising contacting a recipient Bifidobacterium bacterium with a donor bacterium or linear DNA containing DNA to be introduced into the recipient, and performing static culture, wherein a medium used for the static culture has a pH of 6.0 or more and less than 10.0, and the content x (mass %) of sugars that can be assimilated by the recipient Bifidobacterium bacteria satisfies the following: 0 < x ≦ 0.2 × (pH) - 1.2 when the pH is 6.0 or more and less than 8.5, and 0.2 × (pH) - 1.7 < x ≦ 0.2 × (pH) - 1.2 when the pH is 8.5 or more and less than 10.
0.
2. A method for genome manipulation of Bifidobacterium bacteria, comprising contacting a recipient Bifidobacterium bacterium with a donor linear DNA and performing static culture, wherein a medium used for the static culture has a pH of 6.0 or more and less than 10.0, and the content x (mass%) of sugars assimilable by the recipient Bifidobacterium bacterium satisfies 0<x≦0.2×(pH)-1.2 when the pH is 6.0 or more and less than 8.5, and 0.2×(pH)-1.7<x≦0.2×(pH)-1.2 when the pH is 8.5 or more and less than 10.0, and wherein the recipient Bifidobacterium bacterium is a Bifidobacterium bacterium not having an upp gene, The linear DNA as the donor comprises an upstream homology arm, two genes, a selection marker gene and an upp gene, and a downstream homology arm, the two genes being arranged between the upstream homology arm and the downstream homology arm, and the 3'-terminal region of the upstream homology arm being between the two genes and the downstream homology arm, or the 5'-terminal region of the downstream homology arm being between the upstream homology arm and the two genes.
3. The method according to claim 1 or 2, wherein the recipient Bifidobacterium bacterium is a Bifidobacterium bacterium having at least one gene selected from the group consisting of the Tad pilus gene operon, the DNA binding enzyme (ComEA) gene / DNA uptake enzyme (ComEC) gene operon, the DNA processing enzyme (DprA) gene, the nuclease (YraN) gene and the helicase (ComM) gene on its genome.
4. The method according to claim 1 or 2, wherein the osmotic pressure of the medium is 110 to 750 mOsm.
5. The method according to claim 1 or 2, wherein the medium contains 3 to 180 mM MgCl2.
6. A culture medium used in the method for transforming a bacterium of the genus Bifidobacterium according to claim 1 or the method for genome manipulation of a bacterium of the genus Bifidobacterium according to claim 2, wherein the culture medium has a pH of 6.0 or more and less than 10.0, and the content x (mass %) of sugars that can be assimilated by the recipient bacterium of the genus Bifidobacterium satisfies 0<x≦0.2×(pH)-1.2 when the pH is 6.0 or more and less than 8.5, and 0.2×(pH)-1.7<x≦0.2×(pH)-1.2 when the pH is 8.5 or more and less than 10.
0.
7. A kit used in the method for genome manipulation of Bifidobacterium bacteria according to claim 2, comprising a medium having a pH of 6.0 or more and less than 10.0, and a content x (mass %) of sugars assimilable by the recipient Bifidobacterium bacteria which satisfies 0<x≦0.2×(pH)-1.2 when the pH is 6.0 or more and less than 8.5, and 0.2×(pH)-1.7<x≦0.2×(pH)-1.2 when the pH is 8.5 or more and less than 10.0, and a linear DNA comprising a selection marker gene and an upp gene.
